About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
3399 genotypes with 4837 annotations displayed of selected term and subterms
Searched Term: abnormal inflammatory response
Allelic Composition
(Genetic Background)
Annotated Term Reference
1700016L21RikTg(Itgax-DTR/EGFP)57Lan/0
(NOD.FVB-1700016L21RikTg(Itgax-DTR/EGFP)57Lan/Jdk)
insulitis J:137009
2210010C04Riktm1.1Satom/2210010C04Rik+
(B6(FVB)-2210010C04Riktm1.1Satom)
acute pancreas inflammation J:267764
chronic pancreas inflammation J:267764
9030622O22Rikem1Eem/9030622O22Rik+
Foxa2tm1.1Khk/Foxa2+

(involves: 129P2/OlaHsd * C57BL/6 * CD-1)
respiratory system inflammation J:284174
9030622O22Rikem1Eem/9030622O22Rikem1Eem
(involves: C57BL/6 * CD-1)
lung inflammation J:284174
A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
Tg(Myh6-2A)#Know/0

(involves: BALB/c * C57BL/6 * FVB/N)
heart inflammation J:128060
A4gnttm1Jnaka/A4gnttm1Jnaka
(B6.129S6-A4gnttm1Jnaka)
stomach inflammation J:184485
Ay/a
Apoetm1Unc/Apoetm1Unc

(involves: 129P2/OlaHsd * C57BL/6J * KK/TaJcl)
abnormal inflammatory response J:177084
Abca1tm1Wpfl/Abca1tm1Wpfl
(involves: 129P2/OlaHsd * C57BL/6J)
glomerulonephritis J:64390
uterus inflammation J:64390
Abcb1atm1Bor/Abcb1atm1Bor
(FVB.129P2-Abcb1atm1Bor/TacImx)
colitis J:51190
large intestinal inflammation J:51190
Abcb4tm1Bor/Abcb4tm1Bor
(either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * FVB/N))
bile duct inflammation J:15531, J:21232
liver inflammation J:15531
Abcb4tm1Bor/Abcb4tm1Bor
(involves: 129P2/OlaHsd * FVB/N)
bile duct inflammation J:175015
liver inflammation J:175015
Abcb4tm1Bor/Abcb4tm1Bor
(FVB.129P2-Abcb4tm1Bor/J)
bile duct inflammation J:105357
Abcb4tm1Bor/Abcb4tm1Bor
(involves: 129P2/OlaHsd * BALB/c)
bile duct inflammation J:168123
Abcc1tm1Bor/Abcc1tm1Bor
(involves: 129P2/OlaHsd * FVB)
decreased inflammatory response J:44110
Abcc4tm1Kruh/Abcc4tm1Kruh
(B6.129-Abcc4tm1Kruh)
increased susceptibility to induced colitis J:117326
intestinal inflammation J:117326
small intestinal inflammation J:117326
Abcd1tm1Kds/Y
Abcd2tm1Apuj/Abcd2tm1Apuj

(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6J)
increased inflammatory response J:94583
Abcg1tm1Dgen/Abcg1tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
lung inflammation J:132952
Abcg2tm1.1Ssf/Abcg2tm1.1Ssf
(involves: 129 * C57BL/6 * FVB)
liver inflammation J:201884
Abhd5tm1.1Lqyu/Abhd5tm1.1Lqyu
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+

(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6 * DBA)
liver inflammation J:199570
Abl1tm1Mlg/Abl1tm1Mlg
(involves: 129S/SvEv * C57BL/6J)
lung inflammation J:72875
AbmmDBA/2J/?
(involves: BALB/cByJ * DBA/2J)
myocarditis J:52296
Acantm2Afos/Acantm2Afos
(involves: C57BL/6)
decreased susceptibility to induced arthritis J:122102
Acbd5tm1a(EUCOMM)Wtsi/Acbd5tm1a(EUCOMM)Wtsi
(C57BL/6N-Atm1Brd Acbd5tm1a(EUCOMM)Wtsi/WtsiCnbc)
brain inflammation J:299448
Ace2em1(ACE2)Yowa/Ace2em1(ACE2)Yowa
(C57BL/6-Ace2em1(ACE2)Yowa)
interstitial pneumonia J:288243
Ace2em1Cgen/Y
(C57BL/6-Ace2em1Cgen)
increased susceptibility to induced colitis J:299383
intestinal inflammation J:299383
Ace2em2(ACE2)Gpt/Y
(C57BL/6JGpt-Ace2em2(ACE2)Gpt/Gpt)
lung inflammation J:302150
Ace2em#Yngh/Y
(involves: Kunming)
increased susceptibility to induced colitis J:221616
Ace2tm1a(KOMP)Wtsi/Y
Tg(FOXJ1-cre)F26Htzm/0

(involves: C57BL/6N * C57BL/6NTac)
lung inflammation J:282139
Ace2tm1a(KOMP)Wtsi/Ace2tm1a(KOMP)Wtsi
Tg(FOXJ1-cre)F26Htzm/0

(involves: C57BL/6N * C57BL/6NTac)
lung inflammation J:282139
Ace2tm1Cof/Ace2tm1Cof
(involves: 129S6/SvEvTac * C57BL/6)
increased incidence of corneal inflammation J:289503
Ace2tm1Lex/Ace2tm1Lex
(B6;129S5-Ace2tm1Lex/Mmucd)
lung inflammation J:264991
Ace2tm1Pngr/Y
(involves: 129P2/OlaHsd * C57BL/6)
heart inflammation J:124548
Ace2tm1Pngr/Y
(involves: 129P2/OlaHsd)
lung inflammation J:282139, J:100334
Ace2tm1Pngr/Y
(involves: 129P2/OlaHsd * C57BL/6J)
lung inflammation J:277074
Ace2tm1Pngr/Ace2tm1Pngr
(involves: 129P2/OlaHsd)
lung inflammation J:282139, J:100334
Ace2tm1Pngr/Ace2tm1Pngr
(involves: 129P2/OlaHsd * C57BL/6J)
lung inflammation J:277074
Acetm1Keb/Acetm1Keb
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
kidney inflammation J:33018
Acetm1Mcf/Acetm1Mcf
(Not Specified)
kidney inflammation J:32114
tubulointerstitial nephritis J:32114
Acetm1Unc/Acetm1Unc
(involves: 129P2/OlaHsd * C57BL/6J)
kidney inflammation J:25284
Acetm9Keb/Acetm9Keb
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
kidney inflammation J:185888
Acer1tm1a(EUCOMM)Wtsi/Acer1tm1a(EUCOMM)Wtsi
(C57BL/6N-Acer1tm1a(EUCOMM)Wtsi)
skin inflammation J:235775
Ackr1tm1Scp/Ackr1tm1Scp
(involves: 129P2/OlaHsd * C57BL/6)
increased inflammatory response J:64222
Ackr2tm1Gjg/Ackr2tm1Gjg
(involves: 129/Sv * C57BL/6)
dermatitis J:97607
increased inflammatory response J:97806
Ackr3tm1Jgo/Ackr3+
(involves: 129S/SvEvBrd * C57BL/6)
lung inflammation J:136246
Ackr3tm1Jgo/Ackr3tm1Jgo
(involves: 129S/SvEvBrd * C57BL/6)
lung inflammation J:136246
Acot11tm1Deco/Acot11tm1Deco
(involves: 129S6/SvEvTac * C57BL/6)
decreased inflammatory response J:182660
Acox1lampe1/Acox1lampe1
(involves: C57BL/6J)
liver inflammation J:174942
Actbtm4(cre/ERT2)Npa/Actb+
Sgpl1tm1.1Npa/Sgpl1tm1.1Npa

(involves: BALB/cJ * C57BL/6)
abnormal type IV hypersensitivity reaction J:199525
Acvr1tm1Emsh/Acvr1+
(chimera involves: BALB/c * C57BL/6 * CD-1)
increased inflammatory response J:194134
Adatm1Mw/Adatm1Mw
Tg(PLADA)4118Rkmb/0

(involves: 129S7/SvEvBrd * C57BL/6)
lung inflammation J:73418
Adam7tm1Tigm/Adam7tm1Tigm
(involves: C57BL/6)
spermatic granuloma J:226260
Adam8tm1.1Mdz/Adam8tm1.1Mdz
(DBA/1LacJ-Adam8tm1.1Mdz)
decreased susceptibility to induced arthritis J:155243
Adam17m1Btlr/Adam17m1Btlr
(C57BL/6J-Adam17m1Btlr)
increased susceptibility to induced colitis J:166602
Adam17tm1.1Srj/Adam17tm1.1Srj
(involves: 129S/SvEv * C57BL/6 * SJL)
increased susceptibility to induced colitis J:163380
skin inflammation J:163380
Adam17tm1.2Bbl/Adam17tm1.2Bbl
Il17atm1Yiw/Il17atm1Yiw
Sox9tm3(cre)Crm/Sox9+

(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 * SJL)
dermatitis J:229771
Adam17tm1.2Bbl/Adam17tm1.2Bbl
Il23atm1Dnax/Il23atm1Dnax
Sox9tm3(cre)Crm/Sox9+

(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 * SJL)
dermatitis J:229771
Adam17tm1.2Bbl/Adam17tm1.2Bbl
Sox9tm3(cre)Crm/Sox9+

(B6.129(SJL)-Sox9tm3(cre)Crm Adam17tm1.2Bbl)
dermatitis J:229771
Adam17tm1Bbl/Adam17tm1Bbl
Lyz2tm1(cre)Ifo/0

(involves: 129P2/OlaHsd)
decreased susceptibility to endotoxin shock J:139846
Adam17tm1Bbl/Adam17tm1Bbl
Tg(Mx1-cre)1Cgn/0

(involves: 129P2/OlaHsd * C57BL/6 * CBA)
decreased susceptibility to endotoxin shock J:139846
Adam17tm1Imx/Adam17tm1Imx
(involves: 129 * C57BL/6)
increased incidence of corneal inflammation J:51053
Adam17woe/Adam17woe
(C57BL/6-Adam17woe)
dermatitis J:160781
increased incidence of corneal inflammation J:160781
Adamdec1tm1Dgen/Adamdec1+
(B6.129P2-Adamdec1tm1Dgen)
increased susceptibility to induced colitis J:301741
Adamdec1tm1Dgen/Adamdec1tm1Dgen
(B6.129P2-Adamdec1tm1Dgen)
increased susceptibility to colitis induced morbidity/mortality J:301741
increased susceptibility to induced colitis J:301741
intestinal inflammation J:301741
Adamts5tm1.1Eam/Adamts5+
(involves: 129S5/SvEvBrd)
decreased susceptibility to induced arthritis J:97590
Adamts5tm1.1Eam/Adamts5tm1.1Eam
(involves: 129S5/SvEvBrd)
decreased susceptibility to induced arthritis J:97590
Adamts5tm1Lex/Adamts5tm1Lex
Tg(CMV-cre)1Cgn/0

(involves: 129S5/SvEvBrd * BALB/cJ)
osteoarthritis J:105138
Adamts5tm2.2Lex/Adamts5tm2.2Lex
(B6.129S5-Adamts5tm2.2Lex)
decreased susceptibility to induced arthritis J:175366
Adamts14Gt(511E11)Cmhd/Adamts14Gt(511E11)Cmhd
Adamts2tm1Prc/Adamts2tm1Prc

(involves: 129 * 129S1/Sv * 129X1/SvJ * C57BL/6)
dermatitis J:271185
Adamts18tm1.1Wzha/Adamts18tm1.1Wzha
(involves: 129 * C57BL/6)
increased acute inflammation J:258487
increased susceptibility to induced colitis J:258487
Adcy7tm1.1Pcst/Adcy7tm1.1Pcst
Lyz2tm1(cre)Ifo/Lyz2+

(involves: 129P2/OlaHsd * C57BL/6J)
peritoneal inflammation J:191067
Adm2em1Zhan/Adm2em1Zhan
(Not Specified)
increased inflammatory response J:266495
liver inflammation J:266495
Admtm1Tfjt/Adm+
(involves: C57BL/6 * CBA)
blood vessel inflammation J:102946
Adora2btm1Kra/Adora2btm1Kra
(involves: 129 * C57BL/6J)
abnormal inflammatory response J:111715
Adora2btm1Till/Adora2btm1Till
(B6.129P2-Adora2btm1Till)
increased susceptibility to type I hypersensitivity reaction J:125297
Adora3tm1Jbsn/Adora3tm1Jbsn
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
decreased acute inflammation J:120442
Adtrptm1.1Clu/Adtrptm1.1Clu
(involves: 129S4/SvJaeSor * C57BL/6)
increased inflammatory response J:295059
Aec1NOD/Uf/Aec1NOD/Uf
Aec2NOD/Uf/Aec2NOD/Uf

(B6.NOD-Aec2NOD/Uf Aec1NOD/Uf)
lacrimal gland inflammation J:129282
salivary gland inflammation J:129282
Agnm1MRL/MpJ/Agnm1MRL/MpJ
(involves: C3H/HeJ-Faslpr * MRL/MpJ-Faslpr)
glomerulonephritis J:97786
Agnm2C3H/HeJ/Agnm2MRL/MpJ
(involves: C3H/HeJ-Faslpr * MRL/MpJ-Faslpr)
glomerulonephritis J:97786
Agnm2MRL/MpJ/Agnm2MRL/MpJ
(involves: C3H/HeJ-Faslpr * MRL/MpJ-Faslpr)
glomerulonephritis J:97786
Agnm3C3H/HeJ/Agnm3MRL/MpJ
(involves: C3H/HeJ-Faslpr * MRL/MpJ-Faslpr)
glomerulonephritis J:97786
Agnm3MRL/MpJ/Agnm3MRL/MpJ
(involves: C3H/HeJ-Faslpr * MRL/MpJ-Faslpr)
glomerulonephritis J:97786
Agp1NZB/Agp1NZB
(involves: NZB * NZW)
increased susceptibility to type III hypersensitivity reaction J:6920
Agp1NZB/Agp1NZW
(involves: NZB * NZW)
increased susceptibility to type III hypersensitivity reaction J:6920
Agp2NZB/Agp2NZW
(involves: NZB * NZW)
increased susceptibility to type III hypersensitivity reaction J:6920
Agp2NZW/Agp2NZW
(involves: NZB * NZW)
increased susceptibility to type III hypersensitivity reaction J:6920
Agpat2Gt(OST438470)Lex/Agpat2Gt(OST438470)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
adipose tissue inflammation J:186035
granulomatous inflammation J:186035
liver inflammation J:186035
Agr2tm1.1Lpkn/Agr2tm1.1Lpkn
Gt(ROSA)26Sortm1(cre/ERT)Nat/Gt(ROSA)26Sor+

(involves: 129 * 129S6/SvEvTac * C57BL/6)
colitis J:156704
Agr2tm1.2Erle/Agr2tm1.2Erle
(involves: 129S4/SvJae * FVB/N)
increased susceptibility to induced colitis J:148339
Agr2tm1.2Lpkn/Agr2tm1.2Lpkn
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6)
colitis J:156704
ileum inflammation J:156704
Agttm1Afu/Agttm1Afu
(involves: C57BL/6 * CBA)
tubulointerstitial nephritis J:46506
Agttm1Unc/Agttm1Unc
(involves: 129P2/OlaHsd * C57BL/6J)
tubulointerstitial nephritis J:24156
Agtr1atm1Unc/Agtr1atm1Unc
Agtr1btm1Cof/Agtr1btm1Cof

(involves: 129P2/OlaHsd * C57BL/6)
kidney inflammation J:137944
Ahi1tm1Jgg/Ahi1tm1Jgg
Tg(TCF/Lef1-lacZ)34Efu/0

(involves: 129S1/Sv * 129X1/SvJ)
kidney inflammation J:154321
Ahrb-1/Ahrb-1
(C57BL/6J)
increased inflammatory response J:5244, J:5387
Ahrtm1Bra/Ahrtm1Bra
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
decreased susceptibility to type IV hypersensitivity reaction J:148870
Ahrtm1Bra/Ahrtm1Bra
(B6.129-Ahrtm1Bra/J)
lung inflammation J:118646, J:100359
Ahrtm1Gonz/Ahrtm1Gonz
(involves: 129S4/SvJae * C57BL/6N)
bile duct inflammation J:25048
colitis J:44690
folliculitis J:44690
heart inflammation J:44690
increased inflammatory response J:25048
Ahrtm1Yfk/Ahrtm1Yfk
(involves: 129S/SvEv * C57BL/6J)
urinary bladder inflammation J:179919
Aif1tm1Nsib/Aif1tm1Nsib
(involves: 129S/SvEv * C57BL/6)
decreased susceptibility to induced arthritis J:204462
Aim2tm1.2Arte/Aim2tm1.2Arte
Dnase2atm1Osa/Dnase2atm1Osa
Ifnar1tm1Agt/Ifnar1tm1Agt

(involves: 129 * BALB/c * C57BL/6 * C57BL/6J)
rheumatoid arthritis J:238323
Aimp1Gt(OST58507)Lex/Aimp1Gt(OST58507)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
decreased inflammatory response J:95974
Airetm1.1Doi/Airetm1.1Doi
(involves: 129S2/SvPas * C57BL/6)
stomach inflammation J:119475
Airetm1.1Doi/Airetm1.1Doi
(B6.129S2-Airetm1.1Doi/Doi)
increased incidence of corneal inflammation J:107432
lung inflammation J:107432
salivary gland inflammation J:107432
stomach inflammation J:107432
Airetm1.1Doi/Airetm1.1Doi
(NOD.129S2(B6)-Airetm1.1Doi/Doi)
increased incidence of corneal inflammation J:107432
liver inflammation J:107432
lung inflammation J:107432
ovary inflammation J:107432
pancreas inflammation J:107432
prostate gland inflammation J:107432
salivary gland inflammation J:107432
stomach inflammation J:107432
thyroid gland inflammation J:107432
Airetm1.1Doi/Airetm1.1Doi
(C.129S2-Airetm1.1Doi/Doi)
increased incidence of corneal inflammation J:107432
liver inflammation J:107432
lung inflammation J:107432
ovary inflammation J:107432
prostate gland inflammation J:107432
salivary gland inflammation J:107432
stomach inflammation J:107432
Airetm1.1Doi/Airetm1.1Doi
(SJL.129S2-Airetm1.1Doi/Doi)
liver inflammation J:107432
lung inflammation J:107432
ovary inflammation J:107432
pancreas inflammation J:107432
prostate gland inflammation J:107432
salivary gland inflammation J:107432
stomach inflammation J:107432
Airetm1.1Doi/Airetm1.1Doi
(involves: 129S2/SvPas * C57BL/6 * NOD)
liver inflammation J:107432
lung inflammation J:107432
pancreas inflammation J:107432
salivary gland inflammation J:107432
stomach inflammation J:107432
Airetm1.1Doi/Airetm1.1Doi
(NOD.129S2-Airetm1.1Doi)
chronic pancreas inflammation J:135154
insulitis J:135154
lacrimal gland inflammation J:135154
lung inflammation J:135154
salivary gland inflammation J:135154
stomach inflammation J:135154
thyroid gland inflammation J:135154
uveitis J:135154
Airetm1.1Doi/Airetm1.1Doi
H2b/H2b

(NOD.Cg-Airetm1.1Doi H2b/Doi)
stomach inflammation J:107432
Airetm1.1Doi/Airetm1.1Doi
Idd3C57BL/6/Idd3C57BL/6
Idd5C57BL/10SnJ/Idd5C57BL/10SnJ

(NOD.Cg-Idd3C57BL/6 Idd5C57BL/10SnJ Airetm1.1Doi/Doi)
stomach inflammation J:107432
Airetm1.1Doi/Airetm1.1Doi
Il1r1tm1Imx/Il1r1+

(involves: 129S2/SvPas * 129S7/SvEvBrd * NOD)
keratoconjunctivitis J:163691
lacrimal gland inflammation J:163691
Airetm1.1Doi/Airetm1.1Doi
Il1r1tm1Imx/Il1r1tm1Imx

(involves: 129S2/SvPas * 129S7/SvEvBrd * NOD)
keratoconjunctivitis J:163691
lacrimal gland inflammation J:163691
Airetm1Mand/Aire+
(involves: 129P2/OlaHsd * C57BL/6)
lacrimal gland inflammation J:135154
salivary gland inflammation J:135154
Airetm1Mand/Aire+
(NOD.129P2-Airetm1Mand)
chronic pancreas inflammation J:135154
CNS inflammation J:135154
increased inflammatory response J:188686
insulitis J:135154
lacrimal gland inflammation J:135154
salivary gland inflammation J:135154
thyroid gland inflammation J:135154
Airetm1Mand/Airetm1.1Doi
(NOD.129-Airetm1Mand/Airetm1.1Doi)
chronic pancreas inflammation J:135154
insulitis J:135154
lacrimal gland inflammation J:135154
lung inflammation J:135154
salivary gland inflammation J:135154
stomach inflammation J:135154
thyroid gland inflammation J:135154
uveitis J:135154
Airetm1Mand/Airetm1Mand
(involves: 129P2/OlaHsd * C57BL/6)
eye inflammation J:135154
lacrimal gland inflammation J:135154
salivary gland inflammation J:135154
Airetm1Mmat/Airetm1Mmat
(involves: C57BL/6 * CBA)
lacrimal gland inflammation J:96580
pancreas inflammation J:96580
parotid gland inflammation J:96580
stomach inflammation J:96580
submandibular gland inflammation J:96580
Airetm1Mmat/Airetm1Mmat
(C.Cg-Airetm1Mmat)
stomach inflammation J:96580
Airetm1Pltn/Airetm1Pltn
(involves: 129S4/SvJae * C57BL/6)
liver inflammation J:77873
Airetm1Pltn/Airetm1Pltn
(B6.129S4-Airetm1Pltn)
liver inflammation J:115076
Airetm1Ptsn/Airetm1Ptsn
(C57BL/6-Airetm1Ptsn)
parotid gland inflammation J:145910
sublingual gland inflammation J:145910
uveitis J:145910
vitreous body inflammation J:145910
Airetm1Ptsn/Airetm1Ptsn
(C.B6-Airetm1Ptsn)
stomach inflammation J:174653
Ak7Gt(OST434404)Lex/Ak7Gt(OST434404)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
rhinosinusitis J:185566
Ak7Tg(tetO-Hmox1)67Sami/Ak7Tg(tetO-Hmox1)67Sami
(FVB/N-Ak7Tg(tetO-Hmox1)67Sami)
respiratory system inflammation J:186062
rhinitis J:186062
Akap12tm1Ihg/Akap12tm1Ihg
(involves: 129S4/SvJae * C57BL/6)
liver inflammation J:138882
Aknatm1Mak/Aknatm1Mak
(B6.129P2-Aknatm1Mak)
alveolitis J:233952
increased acute inflammation J:233952
lung inflammation J:233952
Akr1b8tm1Dgen/Akr1b8tm1Dgen
(Not Specified)
increased susceptibility to induced colitis J:301852
Aktiptm1a(EUCOMM)Hmgu/Aktiptm1a(EUCOMM)Hmgu
Trp53tm1Tyj/Trp53tm1Tyj

(involves: 129S2/SvPas * C57BL/6N)
kidney inflammation J:276210
liver inflammation J:276210
lung inflammation J:276210
peritoneal inflammation J:276210
Aldh18a1tm1a(KOMP)Wtsi/Aldh18a1+
(C57BL/6N-Aldh18a1tm1a(KOMP)Wtsi/Wtsi)
skin inflammation J:232539
Aldobtm1(KOMP)Vlcg/Aldobtm1(KOMP)Vlcg
(C57BL/6NTac-Aldobtm1(KOMP)Vlcg)
liver inflammation J:220330
Alms1Gt(XH152)Byg/Alms1Gt(XH152)Byg
(involves: 129P2/OlaHsd * C57BL/6J)
tubulointerstitial nephritis J:100403
Alox5tm1Bhk/Alox5tm1Bhk
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * C57BL/6 * DBA/2))
abnormal inflammatory response J:68714
decreased acute inflammation J:68714
decreased susceptibility to type I hypersensitivity reaction J:68714
Alox5tm1Fun/Alox5tm1Fun
(involves: 129S2/SvPas * C57BL/6)
decreased inflammatory response J:21372, J:75371
Alox5aptm1Bhk/Alox5aptm1Bhk
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
decreased susceptibility to type I hypersensitivity reaction J:39229
Alox5aptm1Bhk/Alox5aptm1Bhk
(involves: 129P2/OlaHsd * 129S/SvEv)
decreased acute inflammation J:39229
Alox5aptm1Jdm/Alox5ap+
(DBA/1LacJ-Alox5aptm1Jdm)
decreased susceptibility to induced arthritis J:100736
Alox5aptm1Jdm/Alox5aptm1Jdm
(DBA/1LacJ-Alox5aptm1Jdm)
decreased inflammatory response J:100736
decreased susceptibility to induced arthritis J:100736
Alox8tm1a(KOMP)Wtsi/Alox8tm1a(KOMP)Wtsi
(C57BL/6N-Alox8tm1a(KOMP)Wtsi/MbpMmucd)
lung inflammation J:277623
Alox15tm1Fun/Alox15tm1Fun
(B6.129S2-Alox15tm1Fun/J)
dermatitis J:119405
Als2tm1Jei/Als2tm1Jei
(involves: 129P2/OlaHsd * C57BL/6J)
CNS inflammation J:104446
amdA/J/amdA/J
(involves: A/J * C57BL/6J)
myocarditis J:2843, J:11025
amdDBA/2J/amdDBA/2J
(B10.D2-H8b/(57N)SnJ)
myocarditis J:11025
AmfrGt(IST12797A11)Tigm/AmfrGt(IST12797A11)Tigm
(C57BL/6-AmfrGt(IST12797A11)Tigm)
liver inflammation J:221247
Ampd3tm1Tm/Ampd3tm1Tm
(Not Specified)
lung inflammation J:201211
Ank1ity16/Ank1ity16
(involves: 129S1/Sv * 129X1/SvJ * DBA/2J)
glomerulonephritis J:199427
Ankank/Ankank
(involves: C3HeB/FeJ * C57BL/6J * JGBF/LeJ)
arthritis J:63420
Ankrd2tm1Krc/Ankrd2tm1Krc
(involves: 129 * Black Swiss)
abnormal inflammatory response J:214867
Ano5em1Huyi/Ano5em1Huyi
(C57BL/6N-Ano5em1Huyi)
periodontium inflammation J:294237
Anta/Anta+
(involves: C57BL/6 * C57BL/10 * C57BR/cd)
glomerulonephritis J:169366
anx/anx
(B6C3Fe a/a-anx/J)
abnormal inflammatory response J:103396
Anxa1tm1Rjf/Anxa1+
(Not Specified)
increased inflammatory response J:81498
Anxa1tm1Rjf/Anxa1tm1Rjf
(Not Specified)
increased inflammatory response J:81498
Anxa1tm1Rjf/Anxa1tm1Rjf
(involves: BALB/c)
increased susceptibility to induced colitis J:142735
Anxa5tm1Epo/Anxa5tm1Epo
(involves: 129P2/OlaHsd * C57BL/6)
abnormal inflammatory response J:117249
decreased susceptibility to type IV hypersensitivity reaction J:117249
Anxa7tm1Pll/Anxa7+
(Not Specified)
pancreas inflammation J:58572
Aoc3tm1Salm/Aoc3tm1Salm
(involves: 129S6/SvEvTac * 129S7/SvEvBrd)
decreased inflammatory response J:95656
Aod1aA/J/?
(involves: A/J * C57BL/6J)
ovary inflammation J:83714
Aod1bC57BL/6J/?
(involves: A/J * C57BL/6J)
ovary inflammation J:83714
Aod3A/J/?
(A/J)
ovary inflammation J:78005
aol/aol
(involves: C3H * C57BL/6)
osteoarthritis J:115238
Ap3b1pe/Ap3b1pe
Hps1ep/Hps1ep

(involves: C3H/He * C3HeB/FeJ * C57BL/6J)
lung inflammation J:85431
Apba3tm1.1Ski/Apba3tm1.1Ski
Lyz2tm1(cre)Ifo/Lyz2+

(B6.129-Apba3tm1.1Ski Lyz2tm1(cre)Ifo)
decreased susceptibility to endotoxin shock J:176742
Apba3tm1.2Ski/Apba3tm1.2Ski
(B6.129-Apba3tm1.2Ski)
decreased susceptibility to endotoxin shock J:176742
ApcMin/Apc+
Esr2tm1Mma/Esr2tm1Mma

(involves: 129S2/SvPas * C57BL/6J)
colitis J:118600
Apctm1Tno/Apc+
Ptentm2Mak/Ptentm2Mak
Tg(Cyp1a1-cre/ERT)1Dwi/0

(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * CBA)
peritoneal inflammation J:143082
Apctm2.1Cip/Apctm2.1Cip
Lect2tm1Ymg/Lect2tm1Ymg
Tg(Ttr-cre/Esr1*)1Vco/0

(B6.Cg-Lect2tm1Ymg Apctm2.1Cip Tg(Ttr-cre/Esr1*)1Vco)
liver inflammation J:184496
Apctm2.1Cip/Apctm2.1Cip
Tg(Ttr-cre/Esr1*)1Vco/0

(B6.Cg-Apctm2.1Cip Tg(Ttr-cre/Esr1*)1Vco)
liver inflammation J:184496
Apcstm1Mpe/Apcs+
(B6.Cg-Apcstm1Mpe)
glomerulonephritis J:90502
Apcstm1Mpe/Apcstm1Mpe
(B6.Cg-Apcstm1Mpe)
glomerulonephritis J:90502
Apcstm1Mpe/Apcstm1Mpe
(129.Cg-Apcstm1Mpe)
glomerulonephritis J:90502
Apcstm1Smae/Apcstm1Smae
(involves: 129S/SvEv * C57BL/6)
decreased susceptibility to endotoxin shock J:71194
Apex1tm1Ecf/Apex1+
(either: (involves: 129/Sv) or (involves: 129/Sv * C57BL/6))
heart inflammation J:70397
myocarditis J:70397
pericarditis J:70397
Apoa4tm1Bres/Apoa4tm1Bres
(B6.129S4-Apoa4tm1Bres)
increased susceptibility to induced colitis J:91357
Apobtm2Sgy/Apobtm2Sgy
Ldlrtm1Her/Ldlrtm1Her
Tg(Ins-Igf2)1Fbos/?

(involves: 129S7/SvEvBrd * C57BL/6 * C57BL/6J * SJL)
aortitis J:227165
Apoetm1Unc/Apoetm1Unc
(B6.129P2-Apoetm1Unc/J)
blood vessel inflammation J:91058
decreased susceptibility to type IV hypersensitivity reaction J:61564
Apoetm1Unc/Apoetm1Unc
(involves: 129P2/OlaHsd * C57BL/6)
lung inflammation J:83615
Apoetm1Unc/Apoetm1Unc
Faslpr/Faslpr

(B6.Cg-Apoetm1Unc Faslpr)
glomerulonephritis J:121671
Apoetm1Unc/Apoetm1Unc
Faslgld/Faslgld

(B6.Cg-Faslgld Apoetm1Unc)
blood vessel inflammation J:91058
kidney inflammation J:200141
Apoetm1Unc/Apoetm1Unc
Gja5tm1Mchn/Gja5tm1Mchn
Tg(TIE2-lacZ)182Sato/0

(involves: 129P2/OlaHsd * BALB/c * C57BL/6)
alveolitis J:162224
Apoetm1Unc/Apoetm1Unc
Itgb3tm1Hyn/Itgb3tm1Hyn

(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
lung inflammation J:83615
Apoetm1Unc/Apoetm1Unc
Klf15tm2Jain/Klf15tm2Jain
Tg(Tagln-cre)1Jjl/0

(involves: 129P2/OlaHsd * FVB/N)
blood vessel inflammation J:203920
Apoetm1Unc/Apoetm1Unc
Ncf1tm1Shl/Ncf1tm1Shl

(involves: 129P2/OlaHsd * 129S2/SvPas)
decreased acute inflammation J:123854
Apoetm1Unc/Apoetm1Unc
Soat1tm1Far/Soat1tm1Far

(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6J)
skin inflammation J:61147
Apoetm1Unc/Apoetm1Unc
Tg(MSR1-Plau)1Ddi/0

(involves: 129P2/OlaHsd * C57BL/6 * SJL)
heart inflammation J:101486
Apptm2.1Ldad/Apptm2.1Ldad
(involves: 129 * C57BL/6J)
myositis J:166989
Apptm3.1Tcs/Apptm3.1Tcs
Mapttm1.1(MAPT)Tcs/Mapttm1.1(MAPT)Tcs

(involves: 129S/SvEv * C57BL/6)
CNS inflammation J:278451
Aprttm1Dwm/Aprttm1Dwm
(129P2/OlaHsd-Aprttm1Dwm)
pyelonephritis J:38450
Aprttm1Jat/Aprttm1Jat
(involves: 129S2/SvPas * Black Swiss)
kidney inflammation J:33255
Aprttm1Jat/Aprttm1Jat
(involves: 129S2/SvPas * C57BL/6J)
kidney inflammation J:33255
Aprttm1Vri/Aprttm1Vri
(involves: 129P2/OlaHsd * C57BL/6)
kidney inflammation J:50874
Aqp3m1Btlr/Aqp3m1Btlr
(C57BL/6J-Aqp3m1Btlr)
increased susceptibility to induced colitis J:153279
Aqp12tm1Rai/Aqp12tm1Rai
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
increased susceptibility to induced pancreatitis J:155920
Artm1Verh/Y
Rnase10tm1(cre)Hht/Rnase10+

(involves: 129S7/SvEvBrd * C57BL/6)
testis inflammation J:173897
Aregtm1Dle/Aregtm1Dle
Egftm1Dle/Egftm1Dle
Tgfatm1Unc/Tgfatm1Unc

(involves: 129P2/OlaHsd * C57BL/6)
dermatitis J:54980
Arel1em1Bbc/Arel1+
(C57BL/6J-Arel1em1Bbc)
decreased acute inflammation J:280563
Arel1em1Bbc/Arel1em1Bbc
(C57BL/6J-Arel1em1Bbc)
decreased acute inflammation J:280563
Arhgap17Gt(RRN062)Byg/Arhgap17Gt(RRN062)Byg
(B6.129P2-Arhgap17Gt(RRN062)Byg)
increased susceptibility to induced colitis J:277297
Arhgap25tm1a(KOMP)Wtsi/Arhgap25tm1a(KOMP)Wtsi
(involves: C57BL/6N)
increased acute inflammation J:240521
Arhgdiatm1Ytk/Arhgdiatm1Ytk
(involves: 129S/SvEv * C57BL/6 * DBA)
tubulointerstitial nephritis J:57995
Arid5bGt(ROSA)75Sor/Arid5bGt(ROSA)75Sor
(involves: 129S4/SvJaeSor)
kidney inflammation J:117491
Arih2tm1Mak/Arih2tm1Mak
(involves: 129P2/OlaHsd * C57BL/6)
dermatitis J:191066
heart inflammation J:191066
increased inflammatory response J:191066
liver inflammation J:191066
lung inflammation J:191066
Arih2tm1Mak/Arih2tm1Mak
(B6.129P2-Arih2tm1Mak)
increased inflammatory response J:191066
Arl3Gt(OST263303)Lex/Arl3Gt(OST263303)Lex
(involves: 129S5/SvEvBrd)
bile duct inflammation J:107331
Arntltm1Bra/Arntltm1Bra
(B6.129-Arntltm1Bra)
increased incidence of corneal inflammation J:110697
Arpc4tm1c(EUCOMM)Wtsi/Arpc4tm1c(EUCOMM)Wtsi
Krt14tm1(cre)Wbm/Krt14+

(B6.Cg-Arpc4tm1c(EUCOMM)Wtsi Krt14tm1(cre)Wbm)
dermatitis J:253986
Arrb2tm1Rjl/Arrb2tm1Rjl
(involves: 129X1/SvJ * C57BL/6)
increased acute inflammation J:112607
increased susceptibility to endotoxin shock J:112607
asa/asa
(either: A/J or BALB/c or DBA/2J)
myocarditis J:2843
Asah1tm1.2Geno/Asah1tm1.2Geno
(involves: C57BL/6)
lung inflammation J:285931
Ash1lGt(AL0395)Wtsi/Ash1lGt(AL0395)Wtsi
(involves: 129P2/OlaHsd * C57BL/6J)
blepharitis J:227516
Ash1lTn(pb-Act-RFP)1.AF0-180T25Zhu/Ash1lTn(pb-Act-RFP)1.AF0-180T25Zhu
(B6.FVB-Ash1lTn(pb-Act-RFP)1.AF0-180T25Zhu)
glomerulonephritis J:208213
increased susceptibility to endotoxin shock J:208213
increased susceptibility to induced arthritis J:208213
Ash1lTn(pb-Act-RFP)1.AF0-180T25Zhu/Ash1lTn(pb-Act-RFP)1.AF0-180T25Zhu
Il6tm1Kopf/Il6tm1Kopf

(B6.Cg-Ash1lTn(pb-Act-RFP)1.AF0-180T25Zhu Il6tm1Kopf)
abnormal inflammatory response J:208213
increased susceptibility to induced arthritis J:208213
Asm2MRL/MpJ/?
(involves: C3H/HeJ-Faslpr * MRL/MpJ-Faslpr)
salivary gland inflammation J:66459
Asq1IQI/Asq1IQI
(involves: IQI * C57BL/6CrSlc)
salivary gland inflammation J:127310
Atf2tm1Glm/Atf2tm1Glm
(involves: 129S2/SvPas)
eye inflammation J:30611
Atf2tm1Glm/Atf2tm1Glm
(C.Cg-Atf2tm1Glm)
increased susceptibility to endotoxin shock J:67176
Atf3tm1Dron/Atf3tm1Dron
(involves: 129X1/SvJ * C57BL/6)
lung inflammation J:140112
Atg5tm1Myok/Atg5tm1Myok
Lyz2tm1(cre)Ifo/Lyz2+

(involves: 129P2/OlaHsd * 129S/SvEv)
glomerulonephritis J:235399
Atg7tm1Tchi/Atg7tm1Tchi
Lyz2tm1(cre)Ifo/Lyz2+

(involves: 129P2/OlaHsd * C57BL/6NCrlj * CBA/JNCrlj)
glomerulonephritis J:235399
Atg7tm1Tchi/Atg7tm1Tchi
Xbp1tm2Glm/Xbp1tm2Glm
Tg(Defa6-icre)1Rsb/0

(involves: 129S6/SvEvTac * C57BL/6 * CBA)
small intestinal inflammation J:206084
Atg7tm1Tchi/Atg7tm1Tchi
Xbp1tm2Glm/Xbp1tm2Glm
Tg(Vil1-cre)997Gum/0

(involves: 129S6/SvEvTac * C57BL/6 * CBA * SJL)
ileum inflammation J:206084
intestinal inflammation J:206084
Atg16l1tm1Aki/Atg16l1tm1Aki
(involves: 129/Sv * C57BL/6)
increased susceptibility to induced colitis J:141420
Atg16l1tm1c(EUCOMM)Wtsi/Atg16l1tm1c(EUCOMM)Wtsi
Tg(Vil1-cre)997Gum/?

(involves: C57BL/6J * C57BL/6N * SJL)
cecum inflammation J:221019
Atg16l1tm1Kuv/Atg16l1tm1Kuv
Tg(Vil1-cre)997Gum/0

(B6.Cg-Atg16l1tm1Kuv Tg(Vil1-cre)997Gum)
increased susceptibility to induced colitis J:269933
small intestinal inflammation J:269933
Atg16l1tm1Kuv/Atg16l1tm1Kuv
Tg(Vil1-cre)997Gum/0
Xbp1tm2Glm/Xbp1tm2Glm

(B6.Cg-Atg16l1tm1Kuv Xbp1tm2Glm Tg(Vil1-cre)997Gum)
small intestinal inflammation J:269933
Atg16l1tm1Kuv/Atg16l1tm1Kuv
Xbp1tm2Glm/Xbp1tm2Glm
Tg(Vil1-cre)997Gum/0

(involves: 129S6/SvEvTac * C57BL/6 * SJL)
ileum inflammation J:206084
intestinal inflammation J:206084
Atp7aMo-blo/Y
(B6.Cg-Atp7aMo-blo/J)
osteoarthritis J:36378
Atrtm1Bal/Atrtm2Bal
Ndor1Tg(UBC-cre/ERT2)1Ejb/0

(involves: 129S/SvEv * 129S2/SvPas * C57BL/6)
kidney inflammation J:123200
AW112010em2Flv/AW112010em2Flv
(involves: C57BL/6N)
decreased susceptibility to induced colitis J:267975
Awat2tm1.2Golc/Y
(involves: 129 * C57BL/6 * C57BL/6J)
blepharitis J:308387
eye inflammation J:308387
Awat2tm1.2Golc/Awat2tm1.2Golc
(involves: 129 * C57BL/6 * C57BL/6J)
blepharitis J:308387
eye inflammation J:308387
Axltm1Grl/Axltm1Grl
Mertktm1Grl/Mertktm1Grl
Tyro3tm1Grl/Tyro3tm1Grl

(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
joint inflammation J:70420
B2mtm1Jae/B2mtm1Jae
Foxp3sfOtcspf/Y

(involves: 129/Rl * 129S2/SvPas)
dermatitis J:20865
B2mtm1Jae/B2mtm1Jae
Tnftm2Gkl/Tnf+

(involves: 129S/SvEv * 129S2/SvPas * C57BL/6J)
small intestinal inflammation J:108572
B2mtm1Unc/B2mtm1Unc
(involves: 129P2/OlaHsd * NOD/Lt)
insulitis J:93557
B2mtm1Unc/B2mtm1Unc
Il2tm1Hor/Il2tm1Hor

(involves: 129 * C57BL/6)
colitis J:39981, J:51450
B3gnt6tm1Lx/B3gnt6tm1Lx
(involves: 129S1/Sv * C57BL/6J)
increased susceptibility to induced colitis J:123826
B3gnt6tm1Lx/B3gnt6tm1Lx
C1galt1tm1.1Rpmc/C1galt1tm1.1Rpmc
Tg(Vil1-cre)997Gum/0

(involves: 129S1/Sv * C57BL/6J * SJL)
small intestinal inflammation J:239765
B4galt1tm1Yiw/B4galt1tm1Yiw
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
decreased acute inflammation J:106669
decreased susceptibility to type IV hypersensitivity reaction J:106669
B4galt1tm1Yiw/B4galt1tm1Yiw
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
glomerulonephritis J:117891
B4gat1tm1Mifu/B4gat1tm1Mifu
Gcnt1tm1Jxm/Gcnt1tm1Jxm

(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
decreased susceptibility to type IV hypersensitivity reaction J:120722
B9d2/Tgfb1tm1Flv/Tgfb1tm2Flv
Tg(Cd4-cre)1Cwi/0

(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
abnormal inflammatory response J:123547
colitis J:123547
B9d2/Tgfb1tm1Flv/Tgfb1tm2Flv
Tnfrsf4tm2(cre)Nik/Tnfrsf4+

(involves: 129S6/SvEvTac * 129X1/SvJ)
colitis J:169839
liver inflammation J:169839
lung inflammation J:169839
B9d2/Tgfb1tm1Flv/B9d2/Tgfb1tm1Flv
Tg(Cd4-cre)1Cwi/?

(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
abnormal inflammatory response J:123547
B9d2/Tgfb1tm1Flv/B9d2+
Tnfrsf4tm2(cre)Nik/Tnfrsf4+

(involves: 129S6/SvEvTac * 129X1/SvJ)
colitis J:169839
liver inflammation J:169839
lung inflammation J:169839
Bag4tm1Yeh/Bag4tm1Yeh
(involves: 129P2/OlaHsd * C57BL/6)
increased inflammatory response J:83559
Bak1tm1Thsn/Bak1tm1Thsn
Baxtm1Sjk/Baxtm2Sjk
Tg(Mx1-cre)1Cgn/0

(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
arthritis J:100463
glomerulonephritis J:100463
Bap1tm1.1Geno/Bap1tm1.1Geno
Gt(ROSA)26Sortm9(cre/ESR1)Arte/Gt(ROSA)26Sor+

(involves: C57BL/6 * C57BL/6NTac)
heart inflammation J:187380
Bbaa1C3H/HeNCr/Bbaa1C3H/HeNCr
(involves: C3H/HeNCr * C57BL/6NCr)
abnormal inflammatory response J:52017
Bbaa1C3H/HeNCr/Bbaa1C57BL/6NCr
(involves: C3H/HeNCr * C57BL/6NCr)
abnormal inflammatory response J:52017
Bbaa3C3H/HeNCr/Bbaa3C3H/HeNCr
(involves: C3H/HeNCr * C57BL/6NCr)
abnormal inflammatory response J:73060
Bbaa3C3H/HeNCr/Bbaa3C57BL/6NCr
(involves: C3H/HeNCr * C57BL/6NCr)
abnormal inflammatory response J:52017
Bbaa10C3H/HeN/?
(involves: C3H/HeN * C57BL/6N)
increased inflammatory response J:73060
Bbaa11C3H/HeN/?
(involves: C3H/HeN * C57BL/6N)
increased inflammatory response J:73060
Bbaa12C3H/HeN/?
(involves: C3H/HeN * C57BL/6N)
increased inflammatory response J:73060
Bbaa13C3H/HeN/?
(involves: C3H/HeN * C57BL/6N)
increased inflammatory response J:73060
Bbaa14C3H/HeJ/?
(involves: C3H/HeN * C57BL/6N)
increased inflammatory response J:73060
Bbaa16C3H/HeN/?
(involves: C3H/HeN * C57BL/6N)
increased inflammatory response J:73060
Bbaa17C3H/HeN/?
(involves: C3H/HeN * C57BL/6N)
increased inflammatory response J:73060
Bbaa18C3H/HeN/?
(involves: C3H/HeN * C57BL/6N)
increased inflammatory response J:73060
Bbaa20C3H/HeJ/?
(involves: C3H/HeN * C57BL/6N)
increased inflammatory response J:73060
Bbaa22C3H/HeN/?
(involves: C3H/HeN * C57BL/6N)
increased inflammatory response J:73060
Bbaa23C3H/HeN/?
(involves: C3H/HeN * C57BL/6N)
increased inflammatory response J:73060
Bbs12tm1.1Vmar/Bbs12tm1.1Vmar
(involves: 129S6/SvEvTac * C57BL/6)
decreased inflammatory response J:189019
Bcap31tm1.1Bwang/Bcap31tm1.1Bwang
Lyz2tm1(cre)Ifo/Lyz2+

(involves: 129P2/OlaHsd * C57BL/6)
increased inflammatory response J:292505
Bcas1tm1Himo/Bcas1tm1Himo
(C57BL/6-Bcas1tm1Himo)
brain inflammation J:242041
Bcl2a1atm1Prys/Bcl2a1atm1Prys
(involves: 129/Sv * C57BL/6J * SJL)
decreased inflammatory response J:74478
Bcl2l11tm1.1Ast/Bcl2l11+
(involves: 129S1/Sv * C57BL/6)
glomerulonephritis J:58641
Bcl2l11tm1.1Ast/Bcl2l11tm1.1Ast
(involves: 129S1/Sv * C57BL/6)
glomerulonephritis J:58641
increased inflammatory response J:58641
Bcl2l14tm1.1Boui/Bcl2l14tm1.1Boui
(involves: C57BL/6)
abnormal susceptibility to induced colitis J:296081
Bcl6tm1Gdba/Bcl6tm1Gdba
Tg(Adipoq-cre)1Evdr/0

(involves: C57BL/6 * FVB/NJ)
adipose tissue inflammation J:271078
Bcl6tm1Htno/Bcl6tm1Htno
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
lung inflammation J:55952
myocarditis J:55952
Bcl6tm1Rdf/Bcl6tm1Rdf
(involves: 129S1/Sv)
heart inflammation J:40769
increased inflammatory response J:40769
liver inflammation J:40769
lung inflammation J:40769
Bcl6tm2Rdf/Bcl6tm2Rdf
(involves: 129S1/Sv)
heart inflammation J:40769
increased inflammatory response J:40769
liver inflammation J:40769
lung inflammation J:40769
Bcrtm1Hkp/Bcrtm1Hkp
(involves: 129S2/SvPas)
increased susceptibility to endotoxin shock J:23804
Bcs1ltm1.1Levp/Bcs1ltm1.1Levp
(B6.129-Bcs1ltm1.1Levp)
liver inflammation J:273501
Bdkrb1tm1Bdr/Bdkrb1tm1Bdr
(involves: 129P2/OlaHsd)
abnormal acute inflammation J:63271
decreased susceptibility to endotoxin shock J:135789
Bdkrb1tm2Bdr/Bdkrb1tm2Bdr
Bdkrb2tm1Jfh/Bdkrb2tm1Jfh

(involves: 129S7/SvEvBrd * C57BL/6)
decreased susceptibility to endotoxin shock J:135789
Becn1tm1Ebr/Becn1tm1Ebr
Lyz2tm1(cre)Ifo/Lyz2+

(involves: 129P2/OlaHsd)
glomerulonephritis J:235399
Bgntm1Mfy/Y
(involves: 129S4/SvJae * C57BL/6)
osteoarthritis J:76203
Bgntm1Mfy/Y
Fmodtm1Aol/Fmodtm1Aol

(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6)
osteoarthritis J:76203
Bgntm1Mfy/Y
Fmodtm1Aol/Fmodtm1Aol

(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ)
accelerated temporomandibular joint osteoarthritis J:112779, J:117908
Bgntm1Mfy/Bgntm1Mfy
(involves: 129S4/SvJae)
osteoarthritis J:222369
Bgntm1Mfy/Bgntm1Mfy
Epyctm1Mhok/Epyctm1Mhok

(involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6J)
osteoarthritis J:222369
Bgntm1Mfy/Bgntm1Mfy
Fmodtm1Aol/Fmodtm1Aol

(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ)
accelerated temporomandibular joint osteoarthritis J:117908
bhe/bhe
(Not Specified)
chronic inflammation J:85113
Bidtm1Sjk/Bidtm1Sjk
(involves: 129X1/SvJ * C57BL/6)
decreased susceptibility to endotoxin shock J:117693
Bin1tm1Gcp/Bin1tm2Gcp
Tg(Wap-cre)11738Mam/0

(involves: 129S6/SvEvTac * C57BL/6 * FVB/N * SJL)
endometrium inflammation J:117330
Bin3tm1Gcp/Bin3tm1Gcp
(involves: 129 * C57BL/6)
liver inflammation J:133313
lung inflammation J:133313
Birc3tm1Rgk/Birc3tm1Rgk
(B6.129X1-Birc3tm1Rgk)
decreased susceptibility to endotoxin shock J:144012
Bld/Bld+
(involves: BALB/cCi)
increased incidence of corneal inflammation J:5076
Blmhtm1Geh/Blmhtm1Geh
(either: (involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J))
dermatitis J:54585
Bloc1s6pa/Bloc1s6pa
(B6.Cg-Bloc1s6pa/J)
lung inflammation J:4098
Bmi1tm1Brn/Bmi1tm1Brn
(either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * FVB))
lung inflammation J:17712
Bmp5se-Ca/Bmp5+
(SEACGn.CB-Bmp5se-Ca)
granulomatous inflammation J:5086
Bmp5se-Ca/Bmp5se-Ca
(CBA/Ca-Bmp5se-Ca)
granulomatous inflammation J:5086
Bmp5se-Ca/Bmp5se-Ca
(SEACGn.CB-Bmp5se-Ca)
granulomatous inflammation J:5086
Bmp5se/Bmp5se
(SEC/1Gn)
granulomatous inflammation J:5086
Bmp5se/Bmp5se
(SEAC/Gn)
granulomatous inflammation J:5086
Bmp7tm1.1Dgra/Bmp7tm1.1Dgra
Tg(Prrx1-cre)1Cjt/0

(involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NTac * SJL/J)
joint inflammation J:221175
osteoarthritis J:221175
Bmp7tm1Rob/Bmp7+
Bmp8atm1Blh/Bmp8atm1Blh

(involves: 129S/SvEv * 129S6/SvEvTac * Black Swiss * C57BL/6)
granulomatous inflammation J:78867
Bmp8atm1Blh/Bmp8a+
Bmp8btm1Blh/Bmp8b+

(involves: 129/Sv * 129S6/SvEvTac * Black Swiss)
granulomatous inflammation J:46927
Bmp8atm1Blh/Bmp8atm1Blh
(involves: 129S6/SvEvTac * Black Swiss)
granulomatous inflammation J:46927
Bmpr1atm2.1Bhr/Bmpr1atm2.1Bhr
Tg(CAG-cre/Esr1*)5Amc/0

(involves: 129S7/SvEvBrd * C57BL/6 * CBA)
stomach inflammation J:163367
Bmpr1atm2.1Bhr/Bmpr1atm2.2Bhr
Tg(Gdf5-cre-ALPP)1Kng/0

(involves: 129 * C57BL/6 * FVB/N-Tg(Gdf5-cre-ALPP)1Kng)
osteoarthritis J:97780
Bmxtm1Ali/Bmxtm1Ali
(involves: 129S1/Sv * 129X1/SvJ)
decreased susceptibility to induced arthritis J:173099
Bpifa1m1Ingm/Bpifa1m1Ingm
(involves: C3HeB/FeJ)
increased susceptibility to otitis media J:221346
lung inflammation J:195535
Braftm1Mmcm/Braftm1Mmcm
Cd207tm2.1(cre)Bjec/Cd207+

(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
liver inflammation J:211690
lung inflammation J:211690
Braftm1Mmcm/Braftm1Mmcm
Tg(Itgax-cre)1-1Reiz/0

(involves: 129P2/OlaHsd * C57BL/6 * CBA)
cytokine storm J:211690
granulomatous inflammation J:211690
increased inflammatory response J:211690
Brca1tm5.1Cxd/Brca1tm5.1Cxd
(involves: 129S6/SvEvTac * FVB/N)
dermatitis J:155810
Brf1tm1Arte/Brf1tm1Arte
Tg(Cyp1a1-cre)1Dwi/0

(involves: C57BL/6 * CBA)
liver inflammation J:285667
Bsgtm1Tmu/Bsgtm1Tmu
(involves: 129S2/SvPas * C57BL/6J)
interstitial pneumonia J:46376
Bsgtm1Tmu/Bsgtm1Tmu
(involves: 129/Sv * 129S2/SvPas)
interstitial pneumonia J:46376
Bsgtm1Tmu/Bsgtm1Tmu
(involves: 129S2/SvPas)
glomerulonephritis J:287636
Btkxid/Btkxid
(CBA/CaHN-Btkxid/J)
decreased acute inflammation J:92639
increased susceptibility to induced colitis J:92639
Btrctm1Paga/Btrctm1Paga
Fbxw11tm1Ybn/Fbxw11tm1Ybn
Tg(Vil1-cre/ERT2)23Syr/?

(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6 * DBA/2)
intestinal inflammation J:206654
Bxs6BXSB/MpJ/Bxs6BXSB/MpJ
(involves: BXSB/MpJ * C57BL/10ScSnOlaHsd)
glomerulonephritis J:145903
Bxs6BXSB/MpJ/Bxs6BXSB/MpJ
X/Yaa

(B10.BXSB-(D13Mit3-D13Mit78) Yaa)
glomerulonephritis J:145049
C1galt1ptl1/C1galt1ptl1
(C57BL/6-C1galt1ptl1)
glomerulonephritis J:115272
kidney inflammation J:115272
C1galt1ptl1/C1galt1ptl1
Rag1tm1Bal/Rag1tm1Bal

(involves: 129S4/SvJae * C57BL/6)
kidney inflammation J:115272
C1qatm1Mjw/C1qatm1Mjw
(involves: 129P2/Ola * 129S/SvEv * C57BL/6)
glomerulonephritis J:47315
C1qtnf3tm1Yiw/C1qtnf3tm1Yiw
(involves: C57BL/6NSlc)
increased susceptibility to induced arthritis J:211893
joint inflammation J:211893
C1qtnf4em1Smoc/C1qtnf4em1Smoc
(C57BL/6J-C1qtnf4em1Smoc/Smoc)
increased susceptibility to endotoxin shock J:302282
C1qtnf6tm1Yiw/C1qtnf6tm1Yiw
(B6.129P2-C1qtnf6tm1Yiw)
increased susceptibility to induced arthritis J:227217
increased susceptibility to type III hypersensitivity reaction J:227217
C3tm1Crr/C3tm1Crr
(involves: 129S4/SvJae * C57BL/6)
liver inflammation J:30152
C3tm1Crr/C3tm1Crr
(B6.129S4-C3tm1Crr)
abnormal inflammatory response J:113463
brain inflammation J:123658
C3tm1Crr/C3tm1Crr
(involves: 129S4/SvJae)
glomerulonephritis J:44715
C3tm1Crr/C3tm1Crr
Tg(Ins2-TFRC/OVA)296Wehi/0

(involves: 129S4/SvJae * C57BL/6)
insulitis J:122114
C3tm1Pkna/C3tm1Pkna
(D1.129P2-C3tm1Pkna)
decreased susceptibility to induced arthritis J:88872
C3ar1tm1Raw/C3ar1tm1Raw
(involves: 129X1/SvJ * C57BL/6)
increased susceptibility to endotoxin shock J:68807
C3ar1tm1Raw/C3ar1tm1Raw
(B6.129X1(B6)-C3ar1tm1Raw)
increased susceptibility to type I hypersensitivity reaction J:80071
C3ar1tm1Raw/C3ar1tm1Raw
Cpn1tm1Raw/Cpn1tm1Raw

(B6.129-C3ar1tm1Raw Cpn1tm1Raw)
increased acute inflammation J:148315
C4btm1Crr/C4btm1Crr
(involves: 129S4/SvJae * C57BL/6)
liver inflammation J:30152
C4btm1Crr/C4btm1Crr
(involves: 129S4/SvJae * C57BL/6J)
glomerulonephritis J:111811
C4btm1Crr/C4btm1Crr
(involves: 129S4/SvJae)
glomerulonephritis J:44715
C5ar2tm1Cge/C5ar2tm1Cge
(B6.129S1-C5ar2tm1Cge)
increased inflammatory response J:104092
C9em1Sjlg/C9em1Sjlg
(C57BL/6-C9em1Sjlg)
decreased susceptibility to endotoxin shock J:301607
C9orf72tm1.1Eggn/C9orf72+
(involves: C57BL/6 * C57BL/6N)
dermatitis J:240357
C9orf72tm1.1Eggn/C9orf72tm1.1Eggn
(involves: C57BL/6 * C57BL/6N)
brain inflammation J:240357
dermatitis J:240357
liver inflammation J:240357
C9orf72tm1Eggn/C9orf72+
(involves: C57BL/6 * C57BL/6N)
dermatitis J:240357
C9orf72tm1Eggn/C9orf72tm1Eggn
(involves: C57BL/6 * C57BL/6N)
dermatitis J:240357
Cacna1ctm2Itl/Cacna1c+
(involves: 129S6/SvEvTac * C57BL/6NTac)
dermatitis J:201506
Cacna2d2tm1Svi/Cacna2d2tm1Svi
(involves: 129S1/Sv * C57BL/6J)
rhinitis J:92396
Camk2gtm1.1Irt/Camk2gtm1.1Irt
(involves: C57BL/6J)
increased susceptibility to colitis induced morbidity/mortality J:243363
increased susceptibility to induced colitis J:243363
Camptm1Rlg/Camptm1Rlg
(involves: 129X1/SvJ * C57BL/6)
increased incidence of corneal inflammation J:199719
Cap2tm1a(EUCOMM)Wtsi/Cap2tm1a(EUCOMM)Wtsi
(involves: C57BL/6J * C57BL/6N)
eye inflammation J:234044
Car2tm1(KOMP)Vlcg/Car2tm1(KOMP)Vlcg
(involves: C57BL/6 * C57BL/6NTac)
pyelonephritis J:216402
Card11m1Btlr/Card11m1Btlr
(C57BL/6J-Card11m1Btlr)
dermatitis J:149767, J:139069
Card11tm1.1Litt/Card11tm1.1Litt
Tnfrsf4tm2(cre)Nik/Tnfrsf4+

(involves: 129P2/OlaHsd * 129X1/SvJ)
respiratory system inflammation J:180410
Card11tm1Xav/Card11tm1Xav
(involves: 129 * C57BL/6)
lung inflammation J:132226
Card11unm/Card11unm
(C57BL/6JSfdAnu-Card11unm/Anu)
dermatitis J:84042
erythroderma J:84042
increased inflammatory response J:84042
Card14em1Tshu/Card14em1Tshu
(C57BL/6-Card14em1Tshu)
decreased susceptibility to chemically induced skin inflammation J:289239
Card14em2Tshu/Card14+
(involves: C57BL/6)
skin inflammation J:289239
Card14em3Tshu/Card14+
(involves: C57BL/6)
skin inflammation J:289239
Card14em3Tshu/Card14+
Il17atm1Cdon/Il17atm1Cdon

(involves: C57BL/6)
decreased inflammatory response J:289239
Card14em9Lutzy/Card14+
(C57BL/6J-Card14em9Lutzy/J)
skin inflammation J:262723
Card14tm1Lex/Card14tm1Lex
(B6.129S-Card14tm1Lex)
decreased susceptibility to chemically induced skin inflammation J:253409
Casp1tm1Flv/Casp1tm1Flv
Casp4del/Casp4del

(involves: 129S2/SvPas * C57BL/6)
decreased susceptibility to endotoxin shock J:43088
Casp1tm1Flv/Casp1tm1Flv
Casp4del/Casp4del

(B6.129S2-Casp1tm1Flv)
increased susceptibility to induced colitis J:173245
Casp1tm1Flv/Casp1tm1Flv
Casp4del/Casp4del
Il1r1tm1Imx/Il1r1tm1Imx

(involves: 129S2/SvPas * 129S7/SvEvBrd * C57BL/6)
decreased susceptibility to endotoxin shock J:43088
Casp1tm1Flv/Casp1tm1Flv
Casp4del/Casp4del
Slc11a1s/Slc11a1s

(B6.129S2-Casp1tm1Flv)
cecum inflammation J:124378
Casp1tm1Sesh/Casp1tm1Sesh
Casp4del/Casp4del

(involves: 129S2/SvPas * C57BL/6)
abnormal inflammatory response J:80568
decreased susceptibility to endotoxin shock J:22964, J:40691
Casp1tm1Sesh/Casp1tm1Sesh
Casp4del/Casp4del

(B10.Cg-Casp1tm1Sesh Casp4del H2r H2-T18b)
decreased inflammatory response J:63488
Casp1tm1Sesh/Casp1tm1Sesh
Casp4del/Casp4del

(B6.129S2(NOD)-Casp1tm1Sesh Casp4del)
decreased susceptibility to endotoxin shock J:193522
Casp1tm1Sesh/Casp1tm1Sesh
Casp4del/Casp4del
Tg(Casp4)#Gne/0

(involves: 129S2/SvPas * C57BL/6 * NOD/ShiLtJ)
decreased susceptibility to endotoxin shock J:193522
Casp3tm1Mak/Casp3tm1Mak
(B6.129P2-Casp3tm1Mak)
decreased inflammatory response J:97650, J:179279
Casp4tm1.1Vmd/Casp4tm1.1Vmd
(involves: C57BL/6)
decreased susceptibility to endotoxin shock J:193522
Casp4tm1Yuan/Casp4tm1Yuan
(involves: 129S4/SvJae * C57BL/6J * DBA/2)
decreased susceptibility to endotoxin shock J:46167
Casp8tm1.1Raz/Casp8tm1.1Raz
Ripk3tm1Vmd/Ripk3tm1Vmd

(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)
increased inflammatory response J:170815
Casp8tm1Clie/Casp8tm1Clie
Tg(Alb1-cre)7Gsc/0

(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
liver inflammation J:218665
Casp8tm1Hed/Casp8tm1Hed
Tg(KRT14-cre)1Efu/0

(Not Specified)
dermatitis J:167299
Casp12tm1Dwni/Casp12tm1Dwni
(involves: 129S1/SvImJ * C57BL/6)
increased susceptibility to endotoxin shock J:144912
CasrNuf/CasrNuf
(involves: 102/El * C3H/He)
tongue inflammation J:92612
Cav1tm1Mls/Cav1tm1Mls
(involves: 129/Sv * C57BL/6 * SJL)
decreased susceptibility to endotoxin shock J:139304
lung inflammation J:87282
Cav1tm1Mls/Cav1tm1Mls
Cav3tm1Mls/Cav3tm1Mls

(involves: 129/Sv * C57BL/6J * SJL)
heart inflammation J:77372
Cbfa2t2tm1Swh/Cbfa2t2tm1Swh
(either: B6.129S6-Cbfa2t2tm1Swh or (involves: 129S6/SvEvTac * C57BL/6))
small intestinal inflammation J:102172
Cbfbtm1Itan/Cbfbtm1Itan
Tg(Cd4-cre)1Cwi/0

(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
lung inflammation J:125953
Cbltm1.1Hua/Cbltm1.1Hua
Lattm1Les/Lattm1Les

(involves: 129P2/OlaHsd)
liver inflammation J:91369
lung inflammation J:91369
Cbltm1.1Hua/Cbltm1.1Hua
Lcp2tm1Gak/Lcp2tm1Gak

(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)
liver inflammation J:91369
lung inflammation J:91369
Cbltm2Hua/Cbltm2Hua
Cblbtm1Hua/Cblbtm1Hua
Tg(Lck-cre)I57Jxm/0

(involves: 129P2/OlaHsd * C57BL/6 * ICR)
dermatitis J:80427
Cbstm1Unc/Cbstm1Unc
(involves: 129P2/OlaHsd * C57BL/6J)
liver inflammation J:101303
Cby1tm1Ktkm/Cby1tm1Ktkm
(B6.129-Cby1tm1Ktkm)
increased susceptibility to otitis media J:147413
sinus inflammation J:147413
Cckbrtm1Tom/Cckbrtm1Tom
(involves: 129S4/SvJae * C57BL/6J)
decreased susceptibility to endotoxin shock J:143853
Ccl1tm1Sman/Ccl1tm1Sman
(B6.129-Ccl1tm1Sman)
abnormal inflammatory response J:138942
Ccl2tm1Rol/Ccl2tm1Rol
(involves: 129S4/SvJae * 129X1/SvJ * C57BL/6)
decreased susceptibility to type IV hypersensitivity reaction J:45920
Ccl2tm1Rol/Ccl2tm1Rol
(involves: 129S4/SvJae * C57BL/6)
decreased susceptibility to induced colitis J:116878
Ccl2tm1Rol/Ccl2tm1Rol
(involves: 129S4/SvJae)
decreased inflammatory response J:155025
Ccl3tm1Unc/Ccl3tm1Unc
(involves: 129P2/OlaHsd)
cecum inflammation J:107677
Ccl3tm1Unc/Ccl3tm1Unc
(B6.129P2-Ccl3tm1Unc/J)
decreased susceptibility to type III hypersensitivity reaction J:94599
Ccl3tm1Unc/Ccl3tm1Unc
Hexbtm1Rlp/Hexbtm1Rlp

(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
CNS inflammation J:90687
Ccl5tm1Hso/Ccl5tm1Hso
(involves: 129P2/OlaHsd * C57BL/6)
decreased susceptibility to type IV hypersensitivity reaction J:75842
Ccl11tm1Mer/Ccl11tm1Mer
Ccl24tm1Mer/Ccl24tm1Mer

(129S.129S6(Cg)-Ccl24tm1Mer Ccl11tm1Mer)
abnormal inflammatory response J:102034
Ccl17tm1.1Ifo/Ccl17tm1.1Ifo
(involves: 129P2/OlaHsd * C57BL/6)
decreased susceptibility to type IV hypersensitivity reaction J:159098
Ccl21atm1Yout/Ccl21atm1Yout
(involves: C57BL/6NCrlj * CBA/JNCrlj)
lacrimal gland inflammation J:244640
Ccl25tm1.1Mal/Ccl25tm1.1Mal
Tnftm2Gkl/Tnf+

(involves: 129S/SvEv * 129S2/SvPas * C57BL/6)
intestinal inflammation J:136667
Ccl28tm1Takna/Ccl28tm1Takna
(C57BL/6J-Ccl28tm1Takna)
increased susceptibility to induced colitis J:256896
Ccm2tm1Kwhi/Ccm2tm1.1Kwhi
Tg(Pdgfb-icre/ERT2,-EGFP)1Frut/?

(involves: C57BL/6 * CBA)
CNS inflammation J:173947
Ccpg1tm1a(EUCOMM)Hmgu/Ccpg1tm1a(EUCOMM)Hmgu
(C57BL/6N-Ccpg1tm1a(EUCOMM)Hmgu)
pancreas inflammation J:256708
Ccr1tm1Cge/Ccr1tm1Cge
(involves: 129S4/SvJae)
glomerulonephritis J:115119
increased susceptibility to type IV hypersensitivity reaction J:115119
lung inflammation J:43569
Ccr1tm1Cge/Ccr1tm1Cge
(involves: 129S4/SvJae * C57BL/6)
cecum inflammation J:107677
Ccr1tm1Gao/Ccr1tm1Gao
(involves: 129S4/SvJae * C57BL/6)
granulomatous inflammation J:41324
Ccr1tm1Gao/Ccr1tm1Gao
(involves: C57BL/6)
decreased susceptibility to type III hypersensitivity reaction J:94599
Ccr1tm1Gao/Ccr1tm1Gao
(B6.129S4-Ccr1tm1Gao)
bronchiolitis J:162707
Ccr2tm1Blck/Ccr2tm1Blck
Faslpr/Faslpr

(MRL.Cg-Ccr2tm1Blck Faslpr)
glomerulonephritis J:113343
kidney inflammation J:113343
Ccr2tm1Brv/Ccr2tm1Brv
(involves: 129S1/Sv * ICR)
liver inflammation J:111517
Ccr2tm1Ifc/Ccr2tm1Ifc
(B6.129S4-Ccr2tm1Ifc/J)
decreased acute inflammation J:106738
Ccr2tm1Ifc/Ccr2tm1Ifc
(involves: 129S4/SvJae * C57BL/6)
decreased inflammatory response J:44345
decreased susceptibility to type I hypersensitivity reaction J:118971
Ccr2tm1Ifc/Ccr2tm1Ifc
(B6.129S4-Ccr2tm1Ifc)
decreased susceptibility to induced colitis J:161138
Ccr2tm1Mae/Ccr2tm1Mae
(involves: 129P2/OlaHsd * C57BL/6J)
decreased inflammatory response J:110814
increased susceptibility to induced colitis J:110814
Ccr2tm1Mae/Ccr2tm1Mae
(B6.129P2-Ccr2tm1Mae)
bronchiolitis J:162707
Ccr4tm1Pwr/Ccr4tm1Pwr
(involves: 129P2/OlaHsd * C57BL/6)
decreased susceptibility to endotoxin shock J:70088
Ccr5tm1Brv/Ccr5tm1Brv
(either: (involves: 129S1/Sv * ICR) or (involves: 129S1/Sv * 129X1/SvJ * ICR))
decreased susceptibility to endotoxin shock J:46941
increased susceptibility to type IV hypersensitivity reaction J:46941
Ccr5tm1Kuz/Ccr5tm1Kuz
(involves: 129P2/OlaHsd * C57BL/6)
decreased susceptibility to induced colitis J:110814
Ccr5tm1Kuz/Ccr5tm1Kuz
(B6.129P2-Ccr5tm1Kuz)
bronchiolitis J:162707
Ccr5tm1Kuz/Ccr5tm1Kuz
(involves: 129P2/OlaHsd)
decreased inflammatory response J:227458
Ccr6tm1.1Jmf/Ccr6tm1.1Jmf
(B6.129-Ccr6tm1.1Jmf)
decreased inflammatory response J:152716
Ccr6tm1Gma/Ccr6tm1Gma
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
decreased inflammatory response J:68191
Ccr6tm1Lira/Ccr6tm1Lira
(involves: 129 * C57BL/6)
decreased inflammatory response J:124358
Ccr6tm1Lira/Ccr6tm1Lira
(B6.129-Ccr6tm1Lira)
decreased susceptibility to type I hypersensitivity reaction J:71096
Ccr7tm1Dgen/Ccr7tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
chronic inflammation J:101679
Ccr7tm1Rfor/Ccr7tm1Rfor
(involves: 129P2/OlaHsd * BALB/c)
decreased susceptibility to type IV hypersensitivity reaction J:57976
Ccr7tm1Rfor/Ccr7tm1Rfor
(B6.129P2-Ccr7tm1Rfor)
increased inflammatory response J:110910
lacrimal gland inflammation J:110910
parotid gland inflammation J:110910
salivary gland inflammation J:110910
submandibular gland inflammation J:110910
Ccr9tm1.1Mal/Ccr9tm1.1Mal
Tnftm2Gkl/Tnf+

(involves: 129S/SvEv * 129S2/SvPas * C57BL/6)
intestinal inflammation J:136667
Ccrl2tm1Lex/Ccrl2tm1Lex
(involves: 129S/SvEvBrd * C57BL/6)
decreased susceptibility to type I hypersensitivity reaction J:140110
Cd1tm1Gru/Cd1tm1Gru
(involves: 129S2/SvPas * BALB/c)
myocarditis J:126220
Cd1d1tm1.2Aben/Cd1d1tm1.2Aben
(B6(C)-Cd1d1tm1.2Aben/J)
lung inflammation J:177038
Cd1d1tm1Crw/Cd1d1tm1Crw
(B6.129S4-Cd1d1tm1Crw)
decreased susceptibility to induced arthritis J:99107
Cd1d1tm1Luc/Cd1d1tm1Luc
(involves: 129S6/SvEvTac * C57BL/6)
decreased acute inflammation J:93915
Cd1d1tm1Luc/Cd1d1tm1Luc
(C.129S6-Cd1d1tm1Luc)
glomerulonephritis J:121187
kidney inflammation J:121187
Cd2apem1Irgu/Cd2apem1Irgu
(C57BL/6-Cd2apem1Irgu)
kidney inflammation J:294238
Cd3etm1Mal/Cd3etm1Mal
Nlrp1aNeut1/Nlrp1aNeut1

(involves: C57BL/6)
skin inflammation J:191055
Cd4tm1Mak/Cd4tm1Mak
(PL.129S2(B6)-Cd4tm1Mak/Rdgz)
brain inflammation J:92227
Cd4tm1Mak/Cd4tm1Mak
(SJL.129S2(B6)-Cd4tm1Mak/Rdgz)
brain inflammation J:92227
Cd4tm1Mak/Cd4tm1Mak
Tnftm2Gkl/Tnf+

(involves: 129S/SvEv * 129S2/SvPas * C57BL/6J)
small intestinal inflammation J:108572
Cd14hdl/Cd14hdl
(C57BL/6-Cd14hdl)
decreased susceptibility to endotoxin shock J:98908
Cd14tm1Frm/Cd14tm1Frm
(involves: 129S4/SvJae)
decreased susceptibility to endotoxin shock J:98908
Cd14tm1Smg/Cd14tm1Smg
(involves: 129S1/Sv * C57BL/6)
decreased susceptibility to endotoxin shock J:32729
Cd19tm1(cre)Cgn/Cd19+
Ep300tm2Reck/Ep300+

(involves: 129/Sv * 129P2/OlaHsd * C57BL/6)
arteritis J:147840
glomerulonephritis J:147840
kidney inflammation J:147840
Cd28tm1Jmg/Cd28tm1Jmg
(B6.129X1-Cd28tm1Jmg)
increased susceptibility to type I hypersensitivity reaction J:149888
Cd28tm1Ltu/Cd28tm1Ltu
Foxp3tm4(YFP/icre)Ayr/Foxp3+

(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
skin inflammation J:194503
Cd28tm1Mak/Cd28tm1Mak
(involves: 129S2/SvPas * C57BL/6)
increased susceptibility to type I hypersensitivity reaction J:149888
Cd28tm1Mak/Cd28tm1Mak
(B6.129S2-Cd28tm1Mak/J)
brain inflammation J:57613
Cd28tm1Mak/Cd28tm1Mak
Cd40lgtm1Flv/Cd40lgtm1Flv

(NOD.Cg-Cd40lgtm1Flv Cd28tm1Mak)
insulitis J:93421
Cd28tm1Mak/Cd28tm1Mak
Ndfip1Gt(RRD002)Byg/Ndfip1Gt(RRD002)Byg

(involves: 129P2/OlaHsd * 129S2/SvPas)
esophageal inflammation J:205692
Cd28tm1Pjl/Cd28tm1Pjl
(involves: 129P2/OlaHsd * C57BL/6)
decreased susceptibility to type IV hypersensitivity reaction J:83722
Cd28tm1Pjl/Cd28tm1Pjl
Tnfrsf9tm1Byk/Tnfrsf9tm1Byk

(either: B6.Cg-Cd28tm1Pjl Tnfrsf9tm1Byk or C.Cg-Cd28tm1Pjl Tnfrsf9tm1Byk)
decreased susceptibility to type IV hypersensitivity reaction J:83722
Cd33tm1Avrk/Cd33tm1Avrk
(involves: 129X1/SvJ * C57BL/6)
decreased inflammatory response J:83728
Cd36obl/Cd36obl
(C57BL/6-Cd36obl)
endophthalmitis J:96018
Cd38tm1Lnd/Cd38tm1Lnd
(NOD.129P2(B6)-Cd38tm1Lnd/LtJ)
insulitis J:108097
Cd40tm1Kik/Cd40tm1Kik
(involves: 129P2/OlaHsd * C57BL/6)
decreased susceptibility to type II hypersensitivity reaction J:61673
Cd40tm1Kik/Cd40tm1Kik
Tg(Tnfsf13b)1Fma/?

(B6.Cg-Cd40tm1Kik Tg(Tnfsf13b)1Fma)
glomerulonephritis J:113556
Cd44tm1Hbg/Cd44+
Tnftm2Gkl/Tnf+

(involves: 129S/SvEv * 129S1/Sv * 129X1/SvJ * C57BL/6)
ileum inflammation J:145626
Cd44tm1Hbg/Cd44tm1Hbg
(involves: 129S1/Sv * 129X1/SvJ)
increased acute inflammation J:131974
Cd44tm1Hbg/Cd44tm1Hbg
Tg(TNF)197Gkl/0

(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
arthritis J:97992
Cd44tm1Mak/Cd44tm1Mak
(B6.129P2-Cd44tm1Mak)
liver inflammation J:69351
lung inflammation J:111216, J:108245
Cd44tm1Mak/Cd44tm1Mak
(D1.129P2-Cd44tm1Mak)
increased susceptibility to induced arthritis J:95275
Cd44tm1Mak/Cd44tm1Mak
(involves: 129P2/OlaHsd * C57BL/6)
decreased acute inflammation J:114341
peritoneal inflammation J:155691
Cd44tm2Kmz/Cd44tm2Kmz
(DBA/1LacJ-Cd44tm2Kmz)
decreased susceptibility to induced arthritis J:74268
Cd44tm2Kmz/Cd44tm2Kmz
(involves: BALB/c * DBA/1)
decreased susceptibility to type IV hypersensitivity reaction J:114317
Cd44tm2Kmz/Cd44tm2Kmz
Selltm2Hyn/Selltm2Hyn

(involves: 129S2/SvPas * BALB/c * DBA/1)
decreased susceptibility to type IV hypersensitivity reaction J:114317
Cd55tm1Song/Cd55tm1Song
Cd59atm1Bpm/Cd59atm1Bpm

(B6.129-Cd55tm1Song Cd59atm1Bpm)
myositis J:113567
Cd59atm1Bpm/Cd59atm1Bpm
(involves: 129)
increased susceptibility to induced arthritis J:146711
Cd59atm1Bpm/Cd59atm1Bpm
(B6.129-Cd59atm1Bpm)
lung inflammation J:123582
myositis J:113567
Cd69tm1Naka/Cd69tm1Naka
(C.129P2-Cd69tm1Naka)
decreased susceptibility to induced arthritis J:84940
Cd72c/Cd72c
Faslpr/Faslpr

(involves: C57BL/6 * C57BL/6JJmsSlc * MRL/Mp)
liver inflammation J:204782
lung inflammation J:204782
Cd72tm1Tsub/Cd72tm1Tsub
(involves: C57BL/6J)
glomerulonephritis J:204782
lung inflammation J:204782
Cd72tm1Tsub/Cd72tm1Tsub
Faslpr/Faslpr

(involves: C57BL/6J * C57BL/6JJmsSlc * MRL/Mp)
glomerulonephritis J:204782
liver inflammation J:204782
lung inflammation J:204782
Cd74tm1Liz/Cd74tm1Liz
(B6.129S-Cd74tm1Liz)
decreased susceptibility to type IV hypersensitivity reaction J:125654
Cd80tm1Shr/Cd80tm1Shr
Cd86tm1Shr/Cd86tm1Shr

(B6.129S4-Cd80tm1Shr Cd86tm1Shr)
brain inflammation J:57613
Cd80tm1Shr/Cd80tm1Shr
Cd86tm2Shr/Cd86tm2Shr

(involves: 129S4/SvJae * NOD)
insulitis J:61905
Cd80tm1Shr/Cd80tm1Shr
Cd86tm2Shr/Cd86tm2Shr
Tg(Ighm-Ctla4Ig/Cd80)1Jbs/0

(involves: 129S4/SvJae * FVB/N * NOD)
insulitis J:113109
Cd81tm1Lvy/Cd81tm1Lvy
(CByJ.129-Cd81tm1Lvy)
decreased susceptibility to type I hypersensitivity reaction J:46171
Cd83lcd4/Cd83lcd4
(involves: C57BL/6J)
decreased susceptibility to type IV hypersensitivity reaction J:92721
Cd83tm1Tft/Cd83tm1Tft
(involves: 129S4/SvJae * C57BL/6)
decreased susceptibility to type IV hypersensitivity reaction J:75700
Cd96tm1.1Mjs/Cd96tm1.1Mjs
(B6.129P2(Cg)-Cd96tm1.1Mjs)
increased inflammatory response J:209990
increased susceptibility to endotoxin shock J:209990
Cd99l2tm1.1Dvst/Cd99l2tm1.1Dvst
Tg(Tek-cre)1Ywa/0

(involves: 129S6/SvEvTac * BALB/c * C57BL/6)
decreased susceptibility to type IV hypersensitivity reaction J:193021
Cd109tm1Mat/Cd109tm1Mat
(involves: 129S6/SvEvTac * C57BL/6J)
skin inflammation J:188696
Cd151tm1Nki/Cd151tm1Nki
(involves: 129P2/OlaHsd * FVB/N)
tubulointerstitial nephritis J:114988
Cd163tm1(KOMP)Vlcg/Cd163tm1(KOMP)Vlcg
(involves: C57BL/6NTac)
lung inflammation J:233977
Cd180tm1Kmiy/Cd180tm1Kmiy
Faslpr/Faslpr

(MRL.Cg-Cd180tm1Kmiy Faslpr)
blood vessel inflammation J:137066
glomerulonephritis J:137066
Cd200tm1Jods/Cd200tm1Jods
(C57BL/6-Cd200tm1Jods)
increased susceptibility to induced arthritis J:65982
Cd207tm1(DTR/EGFP)Bjec/Cd207+
(involves: C57BL/6 * SJL)
decreased susceptibility to type IV hypersensitivity reaction J:137517
Cd207tm1(DTR/EGFP)Bjec/Cd207+
(involves: C57BL/6)
abnormal type IV hypersensitivity reaction J:179630
Cd207tm2.1(cre)Bjec/Cd207+
Tgfbr1tm1.1Karl/Tgfbr1tm1.1Karl

(involves: 129S4/SvJaeSor * C57BL/6)
abnormal type IV hypersensitivity reaction J:179630
Cd209atm1.1Cfg/Cd209atm1.1Cfg
(involves: C57BL/6)
increased inflammatory response J:217719
Cd209btm1.1Cfg/Cd209btm1.1Cfg
(involves: C57BL/6)
urinary bladder inflammation J:288225
Cd209btm1Anjm/Cd209btm1Anjm
(B6.129P2-Cd209btm1Anjm)
decreased susceptibility to endotoxin shock J:159646
decreased susceptibility to induced colitis J:159646
Cd226tm1.1Cln/Cd226tm1.1Cln
(B6.129P2-Cd226tm1.1Cln)
decreased inflammatory response J:209990
Cd274tm1Lpc/Cd274tm1Lpc
(C.129S-Cd274tm1Lpc)
increased susceptibility to induced arthritis J:165841
Cd276tm1Lpc/Cd276tm1Lpc
(B6.129-Cd276tm1Lpc)
increased susceptibility to type I hypersensitivity reaction J:237700
Cd276tm1Lpc/Cd276tm1Lpc
(D1J.129-Cd276tm1Lpc)
decreased susceptibility to induced arthritis J:237700
Cd276tm1Mak/Cd276tm1Mak
(involves: 129P2/OlaHsd * C57BL/6)
increased inflammatory response J:84973
Cd276tm1Mak/Cd276tm1Mak
(C.129P2-Cd276tm1Mak)
increased inflammatory response J:84973
Cd300lftm1Toki/Cd300lftm1Toki
(Not Specified)
increased susceptibility to type I hypersensitivity reaction J:190979
respiratory system inflammation J:190979
Cdcs1C3H/HeJBir/Cdcs1C57BL/6J
(involves: C3H/HeJBir-Il10tm1Cgn * C57BL/6J-Il10tm1Cgn)
colitis J:72978
Cdcs2C3H/HeJBir/Cdcs2C3H/HeJBir
(involves: B6.129P2-Il10tm1Cgn/Lt * C3Bir.129P2(B6)-Il10tm1Cgn/Lt)
intestinal inflammation J:72978
Cdcs2C3H/HeJBir/Cdcs2C57BL/6J
(involves: B6.129P2-Il10tm1Cgn/Lt * C3Bir.129P2(B6)-Il10tm1Cgn/Lt)
intestinal inflammation J:72978
Cdcs3C3H/HeJBir/Cdcs3C3H/HeJBir
(involves: B6.129P2-Il10tm1Cgn/Lt * C3Bir.129P2(B6)-Il10tm1Cgn/Lt)
intestinal inflammation J:72978
Cdcs4C3H/HeJBir/Cdcs4C57BL/6J
(involves: C3H/HeJBir * C57BL/6J)
intestinal inflammation J:72978
Cdcs4C57BL/6J/Cdcs4C57BL/6J
(involves: C3H/HeJBir * C57BL/6J)
intestinal inflammation J:72978
Cdcs5C57BL/6J/Cdcs5C57BL/6J
(involves: C3H/HeJBir * C57BL/6J)
intestinal inflammation J:72978
Cdcs6C57BL/6J/?
(involves: B6.129P2-Il10tm1Cgn/Lt * C3Bir.129P2(B6)-Il10tm1Cgn/Lt)
intestinal inflammation J:72978
Cdcs7C3H/HeJBir/Cdcs7C3H/HeJBir
(involves: C3H/HeJBir * C57BL/6J)
intestinal inflammation J:78917
Cdcs8C57BL/6J/Cdcs8C57BL/6J
(involves: C3H/HeJBir * C57BL/6J)
intestinal inflammation J:78917
Cdcs9C3H/HeJBir/Cdcs9C3H/HeJBir
(involves: C3H/HeJBir * C57BL/6J)
intestinal inflammation J:78917
Cdcs9C3H/HeJBir/Cdcs9C57BL/6J
(involves: C3H/HeJBir * C57BL/6J)
intestinal inflammation J:78917
Cdcs10C3H/HeJBir/Cdcs10C3H/HeJBir
(involves: C3H/HeJBir-Il10tm1Cgn * C57BL/6J-Il10tm1Cgn)
intestinal inflammation J:78917
Cdcs10C3H/HeJBir/Cdcs10C57BL/6J
(involves: C3H/HeJBir-Il10tm1Cgn * C57BL/6J-Il10tm1Cgn)
intestinal inflammation J:72978
Cdh17M1Btlr/Cdh17M1Btlr
(C57BL/6J-Cdh17M1Btlr)
increased susceptibility to induced colitis J:272090
Cdkn1atm1Led/Cdkn1atm1Led
Gadd45atm1Ajf/Gadd45atm1Ajf

(either: (involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6) or (involves: 129S6/SvEvTac * 129X1/SvJ * C57BL/6))
glomerulonephritis J:76041
increased inflammatory response J:76041
Cdkn1atm1Tyj/Cdkn1atm1Tyj
(B6;129S2-Cdkn1atm1Tyj/J)
decreased susceptibility to induced arthritis J:108569
Cdkn1atm1Tyj/Cdkn1atm1Tyj
(involves: 129S2/SvPas * C57BL/6)
glomerulonephritis J:60292, J:70894
Cdsntm1.1Ics/Cdsntm1.1Ics
Tg(KRT14-cre/ERT2)1Ipc/0

(involves: 129S2/SvPas)
skin inflammation J:153292
Cebpatm8.1Nerl/Cebpatm8.1Nerl
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6)
liver inflammation J:136134
Cebpbtm1Aki/Cebpbtm1Aki
(involves: 129P2/OlaHsd * C57BL/6)
decreased susceptibility to endotoxin shock J:153025
granulomatous inflammation J:153025
Cebpbtm1Vpo/Cebpbtm1Vpo
(involves: 129S/SvEv * MF1)
decreased susceptibility to type IV hypersensitivity reaction J:25215
glomerulonephritis J:25215
Cebpbtm3Nerl/Cebpbtm3Nerl
(either: B6.129P2-Cebpbtm3Nerl or (involves: 129P2/OlaHsd * C57BL/6))
myositis J:153686
Cebpdtm1Pfj/Cebpdtm1Pfj
(involves: 129S1/Sv * C57BL/6)
decreased inflammatory response J:192313
Cebpetm1Kgx/Cebpetm1Kgx
(involves: 129S6/SvEvTac * NIH Black Swiss)
colitis J:76024
conjunctivitis J:76024
increased inflammatory response J:76024
lung inflammation J:76024
osteomyelitis J:76024
peritoneal inflammation J:76024
rhinitis J:76024
Cebpetm1Kgx/Cebpetm1Kgx
(involves: 129S6/SvEvTac)
colitis J:76024
conjunctivitis J:76024
increased inflammatory response J:76024
lung inflammation J:76024
osteomyelitis J:76024
peritoneal inflammation J:76024
pleuritis J:76024
rhinitis J:76024
Celsr1ctb-2J/Celsr1ctb-2J
(STOCK Celsr1ctb-2J/GrsrJ)
increased susceptibility to otitis media J:229303
Celsr1ctb/Celsr1ctb
(CByJ.Cg-Celsr1ctb/GrsrJ)
increased susceptibility to otitis media J:229303
Cers6tm1.1Arte/Cers6tm1.1Arte
(involves: BALB/cJ * C57BL/6N)
decreased inflammatory response J:215519
Cfbtm1Pkna/Cfbtm1Pkna
(D1.129P2-Cfbtm1Pkna)
decreased susceptibility to induced arthritis J:88872
Cfhtm1Mbo/Cfhtm1Mbo
(involves: 129/Sv * C57BL/6)
glomerulonephritis J:78193
increased susceptibility to type III hypersensitivity reaction J:78193
Cfhtm1Mbo/Cfhtm1Mbo
(involves: 129)
glomerulonephritis J:131403
Cfmq1129X1/SvJ/Cfmq1C57BL/6J
Cftrtm1Unc/Cftrtm1Unc

(involves: 129X1/SvJ * C57BL/6J)
intestinal inflammation J:101842
Cfmq2129X1/SvJ/Cfmq2129X1/SvJ
Cftrtm1Unc/Cftrtm1Unc

(involves: 129X1/SvJ * C57BL/6J)
intestinal inflammation J:101842
Cfmq3129X1/SvJ/Cfmq3C57BL/6J
Cftrtm1Unc/Cftrtm1Unc

(involves: 129X1/SvJ * C57BL/6J)
intestinal inflammation J:101842
Cfptm1Song/Cfptm1Song
(involves: 129 * C57BL/6)
decreased susceptibility to induced arthritis J:165497
Cfptm2.1Song/Cfptm2.1Song
Lyz2tm1(cre)Ifo/Lyz2+

(involves: 129 * 129P2/OlaHsd * C57BL/6 * SJL)
decreased susceptibility to induced arthritis J:165497
Cftrtm1Bay/Cftrtm1Bay
(involves: 129S7/SvEvBrd * C57BL/6J)
acute pancreas inflammation J:15244
Cftrtm1Cam/Cftrtm1Cam
(involves: 129S/SvEv)
peritoneal inflammation J:23850
Cftrtm1Hgu/Cftrtm1Hgu
(involves: 129P2/OlaHsd)
lung inflammation J:24119
Cftrtm1Kth/Cftrtm1Kth
(involves: 129S7/SvEvBrd * C57BL/6J)
peritoneal inflammation J:29074
Cftrtm1Kth/Cftrtm1Kth
(B6.129S7-Cftrtm1Kth)
lung inflammation J:112450
Cftrtm1Unc/Cftrtm1Unc
(B6.129P2-Cftrtm1Unc/J)
lung inflammation J:58571, J:112450
Cftrtm1Unc/Cftrtm1Unc
(involves: 129P2/OlaHsd)
peritoneal inflammation J:2079
Cftrtm1Unc/Cftrtm1Unc
(B6.129P2-Cftrtm1Unc)
lung inflammation J:44904
Cftrtm1Unc/Cftrtm1Unc
Tg(FABPCFTR)1Jaw/0
Tg(Scgb1a1-Scnn1b)6608Bouc/0

(involves: 129P2/OlaHsd * C3H * C57BL/6 * FVB/N)
respiratory system inflammation J:191673
Cftrtm2Cam/Cftrtm2Cam
(involves: 129S/SvEv)
peritoneal inflammation J:27734
Cftrtm2Mrc/Cftrtm2Mrc
(B6.129S6-Cftrtm2Mrc)
lung inflammation J:112450
Cftrtm3Hgu/Cftrtm3Hgu
(involves: 129P2/OlaHsd)
gallbladder inflammation J:32766
peritoneal inflammation J:32766
Cftrtm3Mrc/Cftrtm3Mrc
(B6.129S6-Cftrtm3Mrc)
lung inflammation J:112450
Cgnz1NZM2328/J/Cgnz1NZM2328/J
(involves: C57L/J * NZM2328/J)
kidney inflammation J:71397
Chchd10em8Lutzy/Chchd10+
(C57BL/6NJ-Chchd10em8Lutzy/J)
increased susceptibility to otitis media J:272524
Chd2Gt(RRBO46)Byg/Chd2+
(involves: 129P2/OlaHsd * C57BL/6)
arteritis J:146176
heart inflammation J:146176
interstitial pneumonia J:146743
liver inflammation J:146743
myocarditis J:146743
Chd7Flo/Chd7+
(involves: C3HeB/FeJ)
keratoconjunctivitis sicca J:104123
Chd7Looper/Chd7+
(BALB/c-Chd7Looper)
blepharitis J:252089
conjunctivitis J:252089
Chd7Ome/Chd7+
(involves: BALB/cByJ * C57BL/6J)
increased susceptibility to otitis media J:187200
Chd7Whi/Chd7+
(involves: C3HeB/FeJ)
keratoconjunctivitis sicca J:104123
Chrna3tm1Bay/Chrna3tm1Bay
(involves: 129S7/SvEvBrd * C57BL/6)
urinary bladder inflammation J:54994
Chrnb2tm1Mdb/Chrnb2tm1Mdb
Chrnb4tm1Mdb/Chrnb4tm1Mdb

(involves: 129S7/SvEvBrd * C57BL/6J)
urinary bladder inflammation J:73590
Chsy1skt/Chsy1skt
Pde6b+/Pde6b+

(mixed)
kidney inflammation J:286529
Chsy1tm1Lex/Chsy1tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
arthritis J:171883
Chuktm1Mpa/Chuktm1Mpa
Ikbkbtm2Cgn/Ikbkbtm2Cgn
Tg(Alb1-cre)7Gsc/0

(involves: C57BL/6 * FVB/N)
increased susceptibility to endotoxin shock J:137861
Chuktm2Yhu/Chuktm2Yhu
(involves: 129S1/Sv * 129X1/SvJ * FVB/N)
skin inflammation J:197037
Chuktm2Yhu/Chuktm2Yhu
Tg(Lor-CHUK)8Yhu/0

(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)
lung inflammation J:197037
Cia2DBA/1J/Cia2DBA/1J
(involves: DBA/1J * FVB/N)
increased susceptibility to induced arthritis J:116665
Cia5C57BL/10/Cia5C57BL/10
(involves: B10.RIII * RIIIS/J)
abnormal inflammatory response J:50472
Cia5bRIIIS/J/?
(involves: C57BL/10 * RIIIS/J)
decreased susceptibility to induced arthritis J:101767
Cia5bRIIIS/J/Cia5bRIIIS/J
Cia32B10.RIII/Cia32RIIIS/J

(involves: C57BL/10 * RIIIS/J)
decreased susceptibility to induced arthritis J:101767
Cia5cRIIIS/J/?
(involves: C57BL/10 * RIIIS/J)
decreased susceptibility to induced arthritis J:101767
Cia6C57BL/10SnSg/Cia6C57BL/10SnSg
(involves: B10.Q * DBA/1)
abnormal inflammatory response J:57012
Cia6C57BL/10SnSg/Cia6DBA/1J
(involves: B10.Q * DBA/1)
abnormal inflammatory response J:57012
Cia6DBA/1J/Cia6DBA/1J
(involves: B10.Q * DBA/1)
decreased inflammatory response J:57012
Cia7DBA/1J/Cia7C57BL/10SnSg
(involves: B10.Q * DBA/1)
increased inflammatory response J:57012
Cia7DBA/1J/Cia7DBA/1J
(involves: B10.Q * DBA/1)
increased inflammatory response J:57012
increased susceptibility to induced arthritis J:122130
Cia8DBA/1J/Cia8DBA/1J
(involves: B10.Q * DBA/1)
increased inflammatory response J:57012
Cia9C57BL/10SnSg/Cia9NOD/ShiLtJ
(involves: B10.D1-H2q/SgJ * NOD.C3-H2q/Rhd)
increased inflammatory response J:69981
Cia10C57BL/10/Cia10C57BL/10
(involves: C57BL/10 * RIIIS/J)
abnormal inflammatory response J:50472
Cia10C57BL/10/Cia10C57BL/10
Cia5C57BL/10/Cia5C57BL/10

(involves: C57BL/10 * RIIIS/J)
abnormal inflammatory response J:50472
Cia23C57BL/10SnSg/Cia23C57BL/10SnSg
(involves: B10.D1-H2q/SgJ * NOD.C3-H2q/Rhd)
abnormal inflammatory response J:69981
Cia23C57BL/10SnSg/Cia23NOD/ShiLtJ
(involves: B10.D1-H2q/SgJ * NOD.C3-H2q/Rhd)
abnormal inflammatory response J:69981
Cia23C57BL/10SnSg/Cia23NOD/ShiLtJ
Cia9C57BL/10SnSg/Cia9C57BL/10SnSg

(involves: B10.D1-H2q/SgJ * NOD.C3-H2q/Rhd)
decreased inflammatory response J:69981
Cia26RIIIS/J/Cia26RIIIS/J
Cia30B10.RIII/?

(involves: B10.RIII * RIIIS/J)
arthritis J:95848
Cia30RIIIS/J/Cia30RIIIS/J
Cia5B10.RIII/Cia5B10.RIII

(involves: B10.RIII * RIIIS/J)
decreased susceptibility to induced arthritis J:95848
Cia31B10.RIII/Cia31RIIIS/J
Cia5B10.RIII/Cia5B10.RIII

(involves: B10.RIII * RIIIS/J)
arthritis J:95848
Cia31B10.RIII/Cia31RIIIS/J
Cia5RIIIS/J/Cia5RIIIS/J

(involves: C57BL/10 * RIIIS/J)
decreased susceptibility to induced arthritis J:101767
Cia32B10.RIII/Cia32RIIIS/J
Cia5B10.RIII/Cia5B10.RIII

(involves: B10.RIII * RIIIS/J)
arthritis J:95848
Cia34DBA/1J/Cia34DBA/1J
(involves: C57BL/10 * DBA/1J)
decreased susceptibility to induced arthritis J:122130
Cia35C57BL/10SnSg/Cia35C57BL/10SnSg
Cia42DBA/1J/Cia42DBA/1J

(involves: B10.Q * DBA/1)
decreased susceptibility to induced arthritis J:122130
Cia35C57BL/10SnSg/Cia35DBA/1J
(involves: C57BL/10 * DBA/1J)
increased susceptibility to induced arthritis J:122130
Cia35C57BL/10SnSg/Cia35DBA/1J
Cia42DBA/1J/Cia42DBA/1J

(involves: B10.Q * DBA/1)
decreased susceptibility to induced arthritis J:122130
Cia35DBA/1J/Cia35DBA/1J
Cia42DBA/1J/Cia42DBA/1J

(involves: B10.Q * DBA/1)
decreased susceptibility to induced arthritis J:122130
Cia36DBA/1J/Cia36DBA/1J
(involves: C57BL/10 * DBA/1J)
decreased susceptibility to induced arthritis J:122130
Cia37C57BL/10SnSg/Cia37DBA/1J
(involves: C57BL/10 * DBA/1J)
increased susceptibility to induced arthritis J:122130
Cia38DBA/1J/Cia38DBA/1J
(involves: C57BL/10 * DBA/1J)
increased susceptibility to induced arthritis J:122130
Cia39C57BL/10Sn/Cia39C57BL/10Sn
(involves: B10.Q/Lund-H2q * B10.RIII/Lund-H2r)
decreased susceptibility to induced arthritis J:97801
Cia39RIII/WySn/Cia39RIII/WySn
(involves: B10.Q/Lund-H2q * B10.RIII/Lund-H2r)
arthritis J:97801
Cia40C57BL/10SnSg/Cia40C57BL/10SnSg
(involves: C57BL/10SnSg * DBA/1J * NFS/N)
increased susceptibility to induced arthritis J:106522
Cia43DBA/1J/Cia43FVB/N
(involves: DBA/1J * FVB/N)
increased susceptibility to induced arthritis J:146242
Cia43FVB/N/Cia43FVB/N
(involves: DBA/1J * FVB/N)
increased susceptibility to induced arthritis J:146242
Ciitatm1Ccum/Ciitatm1Ccum
(NOD.129S2(B6)-Ciitatm1Ccum)
abnormal inflammatory response J:106081
insulitis J:107051
pancreas inflammation J:106081
periinsulitis J:106081
Cishtm1.1Cdon/Cishtm1.1Cdon
Tg(Cd4-cre)1Cwi/0

(involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6 * DBA/2)
increased susceptibility to type I hypersensitivity reaction J:204829
Cishtm1.2Cdon/Cishtm1.2Cdon
(B6.129S6(Cg)-Cishtm1.2Cdon)
increased susceptibility to type I hypersensitivity reaction J:204829
lung inflammation J:204829
Clca1tm1.1Lex/Clca1tm1.1Lex
(involves: 129S/SvEvBrd)
increased inflammatory response J:125158
lung inflammation J:125158
Clca1tm1Dgen/Clca1tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
abnormal inflammatory response J:112942
Clcnkam1Btlr/Clcnkam1Btlr
(C57BL/6J-Clcnkam1Btlr)
increased susceptibility to induced colitis J:271974
Clec4a2tm1.1Cfg/Clec4a2tm1.1Cfg
(involves: C57BL/6)
increased inflammatory response J:217719
Clec4a2tm1Yiw/Clec4a2tm1Yiw
(involves: 129P2/OlaHsd * C57BL/6J)
increased inflammatory response J:217720
increased susceptibility to induced arthritis J:217720
joint inflammation J:217720
salivary gland inflammation J:217720
Clec4dtm1.1Cfg/Clec4dtm1.1Cfg
(involves: C57BL/6)
lung inflammation J:203221
Clec4dtm1.1Shoy/Clec4dtm1.1Shoy
(involves: 129P2/OlaHsd * C57BL/6)
decreased susceptibility to type IV hypersensitivity reaction J:203159
granulomatous inflammation J:203159
lung inflammation J:203159
Clec4etm1Tks/Clec4etm1Tks
(involves: 129S1/Sv * 129X1/SvJ)
decreased susceptibility to type IV hypersensitivity reaction J:203159
Clec4gtm1.1Fhe/Clec4gtm1.1Fhe
(B6.129-Clec4gtm1.1Fhe)
liver inflammation J:200968
Clec5atm1Cua/Clec5atm1Cua
(involves: C57BL/6)
decreased susceptibility to induced arthritis J:158811
Clec7atm1Gdb/Clec7atm1Gdb
(involves: 129S6/SvEvTac * C57BL/6)
abnormal inflammatory response J:116669
Clec7atm1Gdb/Clec7atm1Gdb
(B6.129S6-Clec7atm1Gdb)
lung inflammation J:179011
Clec12atm1Jrld/Clec12atm1Jrld
(B6J.129-Clec12atm1Jrld)
increased inflammatory response J:210326
Clic4tm1.1Aidi/Clic4tm1.1Aidi
(involves: C57BL/6 * C57BL/6J)
decreased susceptibility to endotoxin shock J:175404
ClppGt(IST11134F10)Tigm/ClppGt(IST11134F10)Tigm
(involves: C57BL/6N)
dermatitis J:203140
ClppGt(IST13563G11)Tigm/ClppGt(IST13563G11)Tigm
(involves: C57BL/6N)
dermatitis J:203140
Clutm1Jakh/Clutm1Jakh
(involves: Black Swiss * FVB/N)
heart inflammation J:65660
myocarditis J:65660
Cmastm1.1Bwei/Cmastm1.1Bwei
Tg(NPHS2-cre)295Lbh/0

(involves: 129P2/OlaHsd * C57BL/6 * SJL)
tubular nephritis J:286022
Cmklr1tm1Dgen/Cmklr1tm1Dgen
(B6.Cg-Cmklr1tm1Dgen)
increased susceptibility to endotoxin shock J:157190
lung inflammation J:157190
Col1a1Aga2/Col1a1+
(C3HeB/FeJ-Col1a1Aga2)
lung inflammation J:185988
Col1a1M1Jrt/Col1a1+
(involves: C3H/HeJ * C57BL/6J * FVB/NJ)
osteoarthritis J:216423
Col1a1M1Jrt/Col1a1+
(involves: C57BL/6 * FVB/N)
arthritis J:228439
Col1a1tm1(tetO-Fos)Wag/Col1a1+
Tg(KRT5-rtTA)T2D6Sgkd/0

(involves: 129S4/SvJae * C57BL/6 * FVB/N)
skin inflammation J:201145
Col1a1tm3(tetO-Fosl1,-DsRed)Wag/Col1a1+
Tg(Cebpb-tTA)5Bjd/0

(involves: 129S4/SvJae * C57BL/6 * NMRI)
liver inflammation J:210545
Col2a1tm1Prc/Col2a1+
Col9a1tm1Jae/Col9a1tm1Jae

(involves: 129/Sv * 129S2/SvPas)
osteoarthritis J:117910
Col3a1m1Btlr/Col3a1m1Btlr
(C57BL/6J-Col3a1m1Btlr)
increased susceptibility to induced colitis J:271973
Col3a1Tsk2/Col3a1+
(C3H101H-Col3a1Tsk2/H)
adipose tissue inflammation J:31216
skin inflammation J:31216
Col4a1tm1.1Ics/Col4a1+
(involves: 129S2/SvPas * C57BL/6)
kidney inflammation J:240798
Col4a1tm1.1Ics/Col4a1tm1.1Ics
(involves: 129S2/SvPas * C57BL/6)
kidney inflammation J:240798
Col4a3tm1.1Rkl/Col4a3+
(involves: C57BL/6)
glomerulonephritis J:167404
Col4a3tm1Dec/Col4a3tm1Dec
(involves: 129X1/SvJ * C57BL/6)
glomerulonephritis J:37963
Col4a3tm1Dec/Col4a3tm1Dec
(129-Col4a3tm1Dec/J)
glomerulonephritis J:158731
Col4a3tm1Dec/Col4a3tm1Dec
(B6.129X1-Col4a3tm1Dec)
glomerulonephritis J:167404
Col4a3tm1Dec/Col4a3tm1Dec
Itga1tm1Gdnr/Itga1tm1Gdnr

(involves: 129S4/SvJae * 129X1/SvJ * BALB/c)
tubular nephritis J:71378
Col4a3tm1Dec/Col4a3tm1Dec
Sostdc1tm1Myan/Sostdc1tm1Myan

(involves: 129X1/SvJ)
glomerulonephritis J:158731
Col4a3tm1Jhm/Col4a3tm1Jhm
(involves: 129S1/Sv * 129X1/SvJ)
glomerulonephritis J:37017
Col4a3tm1Jhm/Col4a3tm1Jhm
Mmp9tm1Tvu/Mmp9tm1Tvu

(involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ)
glomerulonephritis J:63137
Col4a4bwk/Col4a4bwk
(NON;NZO-Col4a4bwk/J)
kidney inflammation J:223185
tubulointerstitial nephritis J:223185
Col4a4bwk/Col4a4bwk
(D2.NON(NZO)-Col4a4bwk/GrsrJ)
kidney inflammation J:223185
Col4a4bwk/Col4a4bwk
(129S1.NON(NZO)-Col4a4bwk/PgnJ)
kidney inflammation J:223185
Col4a5tm1Yseg/Y
(B6.Cg-Col4a5tm1Yseg)
tubulointerstitial nephritis J:102306
Col9a1tm1Jae/Col9a1tm1Jae
(either: (involves: 129S2/SvPas * BALB/c) or (involves: 129S2/SvPas * C57BL))
osteoarthritis J:18628
Col9a1tm1Jae/Col9a1tm1Jae
(involves: 129S2/SvPas)
osteoarthritis J:117910
Col11a1cho/Col11a1+
(involves: C57BL/6Fr)
osteoarthritis J:106282
Col13a1tm1Pih/Col13a1tm1Pih
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J))
myositis J:71939
Col17a1tm1Tiin/Col17a1tm1Tiin
(involves: C57BL/6)
skin inflammation J:220622
Comptm1Mbri/Comptm1Mbri
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
osteoarthritis J:125086
Coro1aLmb3-C57BL/6Scr/Coro1aLmb3-C57BL/6Scr
(MRL.Cg-Coro1aC57BL/6Scr Faslpr)
glomerulonephritis J:125557
Coro1atm1Achn/Coro1atm1Achn
Coro1btm1.1Nfoe/Coro1btm1.1Nfoe

(involves: 129X1/SvJ * C57BL/6N)
increased susceptibility to type I hypersensitivity reaction J:177785
Cox4i2tm1Hutt/Cox4i2+
(B6.129-Cox4i2tm1Hutt)
lung inflammation J:187640
Cox4i2tm1Hutt/Cox4i2tm1Hutt
(B6.129-Cox4i2tm1Hutt)
lung inflammation J:187640
Cptm1Hrs/Cptm1Hrs
Hephsla/Y

(involves: 129X1/SvJ * C57BL/6)
eye inflammation J:136925
Cpa1tm1.1Satom/Cpa1tm1.1Satom
(involves: C57BL/6NCrl * FVB/N)
pancreas inflammation J:300042
Cpa3tm3(icre)Hrr/Cpa3+
(B6.129P2-Cpa3tm3(icre)Hrr)
abnormal inflammatory response J:178942
Cpa3tm3(icre)Hrr/Cpa3+
(involves: 129P2/OlaHsd * BALB/c * C57BL/6)
decreased susceptibility to type I hypersensitivity reaction J:178942
Cpa3tm3(icre)Hrr/Cpa3+
Fgfr1tm1Upir/Fgfr1tm1Upir
Fgfr2tm1Dor/Fgfr2tm1Dor
Tg(KRT5-cre)5132Jlj/0

(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6 * C57BL/6J * DBA/2J)
skin inflammation J:221184
Cpb2tm1Efp/Cpb2+
Plgtm1Dco/Plg+

(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6)
abnormal inflammatory response J:80114
Cpb2tm1Efp/Cpb2tm1Efp
Plgtm1Dco/Plg+

(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6)
abnormal inflammatory response J:80114
Cpb2tm1Nok/Cpb2tm1Nok
(involves: 129P2/OlaHsd * BALB/c)
increased inflammatory response J:93733
Cpn1tm1Raw/Cpn1tm1Raw
(B6.129S1-Cpn1tm1Raw)
increased acute inflammation J:148315
Cr1ltm1Hmo/Cr1ltm1Hmo
(involves: 129X1/SvJ)
increased inflammatory response J:59432
Creb3l3tm1.1Sad/Creb3l3tm1.1Sad
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)
decreased acute inflammation J:140018
Crhtm1Maj/Crhtm1Maj
(involves: 129S2/SvPas * C57BL/6)
abnormal inflammatory response J:98419
decreased inflammatory response J:90690, J:72196
Crim1Gt(KST264)Byg/Crim1Gt(KST264)Byg
(involves: 129P2/OlaHsd * C57BL/6 * CD-1)
kidney inflammation J:172334
Crlf2tm1Jni/Crlf2tm1Jni
(involves: 129P2/OlaHsd)
respiratory system inflammation J:187770
Crlf2tm1Wjl/Crlf2tm1Wjl
(involves: BALB/c)
lung inflammation J:107431
Crlf2tm1Wjl/Crlf2tm1Wjl
(Not Specified)
colitis J:175844
Crocctm1Tili/Crocctm1Tili
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
lung inflammation J:98885
Crsl/Crsl+
(involves: C3HeB/FeJ)
keratoconjunctivitis sicca J:104123
Cry1tm1Jhjh/Cry1tm1Jhjh
Cry2tm1Jhjh/Cry2tm1Jhjh

(involves: 129P2/OlaHsd * C57BL/6)
increased susceptibility to induced arthritis J:159504
Csf1op/Csf1op
Csf2tm1Ard/Csf2tm1Ard

(involves: 129P2/OlaHsd * C57BL/6)
interstitial pneumonia J:19089
lung inflammation J:19089
Csf1op/Csf1op
Sh3bp2tm1Bjro/Sh3bp2tm1Bjro

(involves: 129S4/SvJae * BALB/cJ * C57BL/6J)
liver inflammation J:117880
Csf2tm1Ard/Csf2tm1Ard
(involves: 129P2/OlaHsd * C57BL/6)
lung inflammation J:18747
Csf2tm1Dran/Csf2tm1Dran
Ifngtm1Ts/Ifngtm1Ts
Il3tm1Glli/Il3tm1Glli

(involves: 129S2/SvPas * 129S7/SvEvBrd * C57BL/6)
increased inflammatory response J:83086
Csf2tm1Dran/Csf2tm1Dran
Il3tm1Glli/Il3tm1Glli

(B6.129S2-Csf2tm1Dran Il3tm1Glli)
decreased susceptibility to type IV hypersensitivity reaction J:67404
glomerulonephritis J:83086
lung inflammation J:67404
Csf2tm1Dran/Csf2tm1Dran
Il3tm1Glli/Il3tm1Glli

(C.129S2-Csf2tm1Dran Il3tm1Glli)
decreased susceptibility to type IV hypersensitivity reaction J:67404
lung inflammation J:67404
Csf2rbtm1Cgb/Csf2rbtm1Cgb
(involves: 129S1/Sv * C57BL/6)
lung inflammation J:29737
Csf2rbtm1Clsc/Csf2rbtm1Clsc
Csf2rb2tm1Cgb/Csf2rb2tm1Cgb

(C.129S1-Csf2rb2tm1Cgb Csf2rbtm1Clsc)
decreased susceptibility to type I hypersensitivity reaction J:130939
Csf2rbtm1Mur/Csf2rbtm1Mur
(involves: 129P2/OlaHsd * C57BL/6)
lung inflammation J:35829
Csf2rbtm1Mur/Csf2rbtm1Mur
(involves: 129P2/OlaHsd)
lung inflammation J:24122
Csf2rbtm1Mur/Csf2rbtm1Mur
Il3tm1Tyb/Il3tm1Tyb

(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
lung inflammation J:35829
Csktm1Tara/Csktm2Tara
Elanetm1(cre)Roes/Elane+

(involves: 129P2/OlaHsd * CB20 * C57BL/6)
increased acute inflammation J:89716
Cstbtm1Rm/Cstbtm1Rm
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
increased incidence of corneal inflammation J:50587
uveitis J:50587
Ct55em1Xdzg/Ct55em1Xdzg
(involves: C57BL/6)
decreased susceptibility to induced colitis J:280149
ctl/ctl
(A/WySnJ-ctl/GrsrJ)
arthritis J:91389
Ctla4tm1All/Ctla4tm1All
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * NOD)
increased acute inflammation J:109887
Ctla4tm1All/Ctla4tm1All
Tg(TcraBDC2.5,TcrbBDC2.5)1Doi/0

(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * NOD * SJL)
increased acute inflammation J:109887
insulitis J:109887
Ctla4tm1Saka/Ctla4tm1Saka
Foxp3tm1(cre)Saka/Y

(involves: BALB/c)
increased inflammatory response J:140085
lung inflammation J:140085
myocarditis J:140085
salivary gland inflammation J:140085
stomach inflammation J:140085
Ctla4tm1Shr/Ctla4tm1Shr
(either: (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6))
joint inflammation J:30393
lung inflammation J:30393
myocarditis J:30393
pancreas inflammation J:30393
salivary gland inflammation J:30393
Ctnnb1tm1(Nfkbia)Rsu/Ctnnb1+
(involves: 129P2/OlaHsd * C57BL/6)
conjunctivitis J:71744
increased inflammatory response J:71744
increased susceptibility to otitis media J:71744
keratoconjunctivitis sicca J:71744
Ctnnb1tm2(Nfkbia)Rsu/Ctnnb1+
Tg(CMV-cre)1Cgn/0

(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6)
increased inflammatory response J:71744
increased susceptibility to otitis media J:71744
keratoconjunctivitis sicca J:71744
Ctnnb1tm4Wbm/Ctnnb1tm4Wbm
Tg(Pdx1-cre)6Tuv/0

(involves: 129P2/OlaHsd * FVB/N)
pancreas inflammation J:119908
Ctrb1em1Toth/Ctrb1em1Toth
(C57BL/6N-Ctrb1em1Toth)
increased susceptibility to induced pancreatitis J:294171, J:294035
Ctrcm1/Ctrcm1
(C57BL/6-Ctrcm1)
increased susceptibility to induced pancreatitis J:291240
Ctsbtm1Jde/Ctsb+
(NOD.129P2-Ctsbtm1Jde)
insulitis J:153355
Ctsbtm1Jde/Ctsbtm1Jde
(NOD.129P2-Ctsbtm1Jde)
insulitis J:153355
salivary gland inflammation J:153355
Ctsetm1Kjy/Ctsetm1Kjy
(involves: C57BL/6)
dermatitis J:108745
Ctsgtm1.1Roes/Ctsgtm1.1Roes
Elanetm1(cre)Roes/Elanetm1(cre)Roes

(involves: 129P2/OlaHsd)
decreased susceptibility to endotoxin shock J:77597
Ctslnkt/Ctslnkt
(either: (involves: 129S2/SvPas * BALB/c) or (involves: 129S2/SvPas * C57BL/6) or (involves: 129S2/SvPas * DBA/2))
dermatitis J:54856
increased inflammatory response J:54856
liver inflammation J:54856
lymph node inflammation J:54856
Ctslnkt/Ctslnkt
(B6.Cg-Ctslnkt)
dermatitis J:78460
Ctslnkt/Ctslnkt
(C.Cg-Ctslnkt)
dermatitis J:78460
Ctsltm1Alpk/Ctsltm1Alpk
(involves: 129P2/OlaHsd * C57BL/6)
dermatitis J:99755
folliculitis J:99755
granulomatous inflammation J:99755
Ctsltm1Alpk/Ctsltm1Alpk
(B6.129P2-Ctsltm1Alpk)
granulomatous inflammation J:99755
Ctsltm1Cptr/Ctsl+
(NOD.129P2-Ctsltm1Cptr)
insulitis J:153355
Ctsltm1Cptr/Ctsltm1Cptr
(NOD.129P2-Ctsltm1Cptr)
salivary gland inflammation J:153355
Ctsstm1Eae/Ctss+
(NOD.D1-Ctsstm1Eae)
insulitis J:153355
Ctsstm1Eae/Ctsstm1Eae
(involves: C57BL/6 * DBA/1LacJ)
decreased susceptibility to induced arthritis J:53399
Ctsstm1Eae/Ctsstm1Eae
(NOD.D1-Ctsstm1Eae)
insulitis J:153355
salivary gland inflammation J:153355
Cuedc2tm1Qxia/Cuedc2tm1Qxia
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NTac)
increased susceptibility to induced colitis J:211782
Cux1tm2Ejn/Cux1tm2Ejn
(involves: 129S4/SvJae * C57BL/6)
rhinitis J:74660
Cuzd1tm1Ljm/Cuzd1tm1Ljm
(involves: 129S6/SvEvTac * Black Swiss)
increased susceptibility to induced pancreatitis J:80980
Cx3cl1tm1.1Yono/Cx3cl1tm1.1Yono
(involves: C57BL/6J)
decreased inflammatory response J:271242
Cx3cr1tm1Litt/Cx3cr1tm1Litt
(involves: 129P2/OlaHsd)
decreased inflammatory response J:271242
Cx3cr1tm1Litt/Cx3cr1tm1Litt
(B6.129P2-Cx3cr1tm1Litt)
brain inflammation J:129712
Cxcl5tm1Gscw/Cxcl5tm1Gscw
(involves: 129)
decreased susceptibility to endotoxin shock J:162629
Cxcl9tm1Jmf/Cxcl9tm1Jmf
(B6.129S4-Cxcl9tm1Jmf)
decreased inflammatory response J:120743
Cxcl10tm1Adl/Cxcl10tm1Adl
(involves: 129S4/SvJae * 129X1/SvJ)
decreased susceptibility to type IV hypersensitivity reaction J:75584
Cxcl10tm1Adl/Cxcl10tm1Adl
(B6.129S4-Cxcl10tm1Adl)
CNS inflammation J:87076
Cxcr2tm1Mwm/Cxcr2tm1Mwm
(C.129S2(B6)-Cxcr2tm1Mwm/J)
decreased susceptibility to induced arthritis J:142880
Cxcr3tm1Raks/Cxcr3tm1Raks
(B6.129P2-Cxcr3tm1Raks)
kidney inflammation J:152790
Cxcr3tm1Wwh/Y
(B6.Cg-Cxcr3tm1Wwh)
lung inflammation J:91359
Cxcr3tm1Wwh/Cxcr3tm1Wwh
(B6.Cg-Cxcr3tm1Wwh)
lung inflammation J:91359
Cxcr4tm1Yiw/Cxcr4tm1Yiw
Tg(Lck-cre)1Jtak/0

(involves: 129P2/OlaHsd)
decreased susceptibility to induced arthritis J:164872
Cybanmf333/Cybanmf333
(A.B6 Tyr+-Cybanmf333/J)
increased inflammatory response J:132359
lung inflammation J:132359
Cybatm1Dgh/Cybatm1Dgh
(B6.Cg-Cybatm1Dgh)
decreased inflammatory response J:231269
Cybbtm1Din/Y
(involves: 129S/SvEv * C57BL/6)
increased inflammatory response J:22868
Cybbtm1Din/Cybbtm1Din
(B6.129S-Cybbtm1Din)
granulomatous inflammation J:146231
increased acute inflammation J:110181
Cybbtm1Din/Cybbtm1Din
(B6.129S-Cybbtm1Din/J)
glomerulonephritis J:235399
Cyldtm1.1Mpa/Cyldtm1.1Mpa
Faddtm1Mpa/Faddtm1Mpa
Tg(Vil1-cre)997Gum/0

(B6.Cg-Faddtm1Mpa Cyldtm1.1Mpa Tg(Vil1-cre)997Gum)
cecum inflammation J:175865
Cyldtm1.1Mpa/Cyldtm1.1Mpa
Ikbkgtm1.1Mpa/Y
Tg(Vil1-cre)997Gum/0

(B6.Cg-Cyldtm1.1Mpa Ikbkgtm1.1Mpa Tg(Vil1-cre)997Gum)
colitis J:175865
Cyldtm1.1Mpa/Cyldtm1.1Mpa
Ikbkgtm1.1Mpa/Ikbkgtm1.1Mpa
Tg(Vil1-cre)997Gum/0

(B6.Cg-Cyldtm1.1Mpa Ikbkgtm1.1Mpa Tg(Vil1-cre)997Gum)
colitis J:175865
Cyldtm1Lex/Cyldtm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
abnormal inflammatory response J:114972
increased susceptibility to induced colitis J:114972
Cyp2ctm1104Arte/Cyp2ctm1104Arte
(B6NTac(Cg)-Cyp2ctm1104Arte/Arte)
liver inflammation J:241121
Cyp2ctm1897.1(Alb-CYP2C9)Arte/Cyp2ctm1897.1(Alb-CYP2C9)Arte
(B6(Cg)-Cyp2ctm1897.1(Alb-CYP2C9)Arte/Arte)
liver inflammation J:241121
Cyp2g1tm1(rtTA)Lane/Cyp2g1+
Tg(SFTPC-rtTA,tetO-Tnf)320-1Gwho/0

(involves: 129 * C57BL/6 * SJL)
rhinitis J:157842
Cyp19a1tm1Esi/Cyp19a1tm1Esi
(involves: 129S6/SvEvTac * C57BL/6)
kidney inflammation J:92438
salivary gland inflammation J:92438
Cyp19a1tm1Sih/Cyp19a1tm1Sih
(involves: 129S/SvEv)
lacrimal gland inflammation J:216958
salivary gland inflammation J:216958
Cys1cpk/Cys1cpk
(129.B6-Cys1cpk)
liver inflammation J:116210
Cysltr1tm1Ykn/Cysltr1tm1Ykn
(involves: C57BL/6)
decreased susceptibility to type I hypersensitivity reaction J:77087
respiratory system inflammation J:88647
Cysltr2tm1Ykn/Cysltr2tm1Ykn
(C57BL/6-Cysltr2tm1Ykn)
decreased susceptibility to type I hypersensitivity reaction J:94488
Cytl1tm1Chun/Cytl1tm1Chun
(involves: 129S4/SvJae * C57BL/6)
increased susceptibility to induced arthritis J:175377
DbaclC57BL/6Jcl/DbaclC57BL/6Jcl
(NOD.B6-(D4Mit193-D4Mit17))
insulitis J:144964
Dcntm1Ioz/Dcntm1Ioz
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss)
tubular nephritis J:75298
Ddctm1.1Rhrs/Ddctm1.1Rhrs
Tg(Ggt1-cre)M3Egn/0

(involves: 129 * C57BL/6 * SJL)
tubulointerstitial nephritis J:175630
Ddctm1.1Rhrs/Ddctm1.1Rhrs
Tg(Ggt1-cre)M3Egn/0

(129.Cg-Ddctm1.1Rhrs Tg(Ggt1-cre)M3Egn)
tubulointerstitial nephritis J:175630
Ddit3tm1Dron/Ddit3tm1Dron
Tg(Col2a1-rtTA,tetO-COMP*)2Jath/0

(involves: 129X1/SvJ * 129S1/Sv * C57BL/6)
decreased inflammatory response J:233238
Ddit3tm2.1Dron/Ddit3tm2.1Dron
(B6.129S(Cg)-Ddit3tm2.1Dron/J)
adipose tissue inflammation J:214136
Ddx58tm1Zgwg/Ddx58tm1Zgwg
(involves: 129S1/Sv)
colitis J:139868
increased susceptibility to induced colitis J:139868
Defb3tm1Xen/Defb3tm1Xen
(involves: C57BL/6)
increased incidence of corneal inflammation J:199719
Del(1Aim2-Ifi205)1Stsn/+
Trex1tm1Tld/Trex1tm1Tld

(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6N)
heart inflammation J:234263
increased inflammatory response J:234263
kidney inflammation J:234263
myositis J:234263
stomach inflammation J:234263
Del(1Aim2-Ifi205)1Stsn/Del(1Aim2-Ifi205)1Stsn
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6N)
stomach inflammation J:234263
Del(1Aim2-Ifi205)1Stsn/Del(1Aim2-Ifi205)1Stsn
Trex1tm1Tld/Trex1tm1Tld

(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6N)
heart inflammation J:234263
increased inflammatory response J:234263
kidney inflammation J:234263
myositis J:234263
stomach inflammation J:234263
Del(6Ephb6-Trpv6)1Mhed/+
(involves: 129S/SvEv)
dermatitis J:133151
Del(6Ephb6-Trpv6)1Mhed/Del(6Ephb6-Trpv6)1Mhed
(involves: 129S/SvEv)
dermatitis J:133151
Del(6Snca)1Slab/Del(6Snca)1Slab
Tg(Th-SNCA*)1Mgsp/0

(involves: C57BL/6J * C57BL/6JOlaHsd * CBA/Ca)
brain inflammation J:108310
Del(9Hspb2-Cryab)1Wawr/Del(9Hspb2-Cryab)1Wawr
(involves: 129S4/SvJae)
osteoarthritis J:72926
Del(10Prmt2-Col6a1)1Yah/+
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
lung inflammation J:167506
respiratory system inflammation J:167506
Del(13Naip1-Naip5)1Vnce/Del(13Naip1-Naip5)1Vnce
(involves: C57BL/6)
decreased inflammatory response J:294930
Del(13Naip1-Naip5)1Vnce/Del(13Naip1-Naip5)1Vnce
Nlrc4em2Vnce/Nlrc4em2Vnce

(involves: C57BL/6)
decreased inflammatory response J:294930
Del(13Naip1-Naip5)1Vnce/Del(13Naip1-Naip5)1Vnce
Nlrp3tm1Vmd/Nlrp3tm1Vmd

(involves: C57BL/6J * C57BL/6N)
decreased inflammatory response J:294930
Del(14Ltb4r2-Ltb4r1)1Bodd/+
(involves: 129S4/SvJaeSor * C57BL/6)
decreased susceptibility to induced arthritis J:131779
Del(14Ltb4r2-Ltb4r1)1Bodd/Del(14Ltb4r2-Ltb4r1)1Bodd
(involves: 129S4/SvJaeSor * C57BL/6)
decreased susceptibility to induced arthritis J:131779
Del(19Poll-Dcpd)1Nmt/Del(19Poll-Dcpd)1Nmt
(involves: 129P2/OlaHsd)
sinus inflammation J:75779
Derm1NC/Nga/Derm1NC/Nga
(involves: MSM/Ms * NC/Nga)
dermatitis J:68698
DermsBALB/cByJ/?
(involves: BALB/cByJ * C3H/HeJ * C57BL/6J * DBA/2J)
dermatitis J:80574
DermsDBA/2J/?
(involves: BALB/cByJ * C3H/HeJ * C57BL/6J * DBA/2J)
dermatitis J:80574
Dgkztm1Gak/Dgkztm1Gak
(involves: 129X1/SvJ * C57BL/6)
abnormal inflammatory response J:293120
decreased susceptibility to induced arthritis J:293120
Dh/Dh+
H2d/H2d

(NZB.Cg-Dh)
glomerulonephritis J:12036
Diaph1tm1Asal/Diaph1tm1Asal
(involves: 129S1/Sv * C57BL/6)
dermatitis J:124319
Dicer1tm1Bdh/Dicer1tm1Bdh
Foxp3tm4(YFP/icre)Ayr/Y

(involves: 129S1/Sv * 129X1/SvJ)
blood vessel inflammation J:138683
liver inflammation J:138683
lung inflammation J:138683
Dicer1tm1Bdh/Dicer1tm1Bdh
Foxp3tm4(YFP/icre)Ayr/Foxp3tm4(YFP/icre)Ayr

(involves: 129S1/Sv * 129X1/SvJ)
blood vessel inflammation J:138683
liver inflammation J:138683
lung inflammation J:138683
Dicer1tm1Bdh/Dicer1tm1Bdh
Tg(Foxp3-EGFP/icre)1aJbs/0

(involves: 129 * NOD/ShiLt)
liver inflammation J:138808
lung inflammation J:138808
Dicer1tm1Tara/Dicer1tm1Tara
Foxn1tm3(cre)Nrm/Foxn1+

(involves: 129P2/OlaHsd * C57BL/6NHsd)
increased susceptibility to induced arthritis J:180783
Dkc1tm1Ppp/Y
(involves: 129S1/Sv)
lung inflammation J:81054
Dlk1tm1.1Jvs/Dlk1+
Myf5tm3(cre)Sor/Myf5+

(involves: 129P2 * 129S4/SvJaeSor * C57BL/6 * FVB/N)
increased inflammatory response J:167124
Dmbt1tm1Janm/Dmbt1tm1Janm
(involves: 129P2/OlaHsd * C57BL/6)
increased susceptibility to induced colitis J:130258
Dmdem1Eno/Y
(involves: C57BL/6J)
myositis J:253191
Dmdem4Eno/Y
(C57BL/6-Dmdem4Eno)
myositis J:285447
Dmdem4Eno/Dmdem4Eno
(C57BL/6-Dmdem4Eno)
myositis J:285447
Dmdmdx/Y
(involves: C57BL/10ScSn)
diaphragmitis J:140282
myositis J:140282
Dmdmdx/Y
Terctm1Rdp/Terctm1Rdp

(involves: 129/Sv * C57BL/6J * C57BL/10ScSn * SJL)
myositis J:167294
Dmdmdx/Y
Tg(DMD*)#Spc/0

(involves: 129P2/OlaHsd * C57BL/10ScSn * DBA/2)
myositis J:280218
Dmdmdx/Y
Utrntm1Jrs/Utrn+

(involves: 129S1/Sv * 129X1/SvJ * C57BL/10ScSn)
diaphragmitis J:140282
myositis J:140282
Dmdmdx/Dmdmdx
(C57BL/10ScSn-Dmdmdx/J)
myositis J:226314
Dmdmdx/Dmdmdx
(D2.B10-Dmdmdx/J)
heart inflammation J:226314
myositis J:226314
Dmdmdx/Dmdmdx
Dusp1tm1Brv/Dusp1tm1Brv

(involves: 129S2/SvPas * C57BL/6 * C57BL/10ScSn)
myositis J:162340
Dmdtm1.1Know/Dmdtm1.1Know
(involves: C3H)
myocarditis J:207775
Dmdtm1Kmf/Y
(involves: C57BL/6)
myositis J:233298
Dnah5Tg1Htz/Dnah5Tg1Htz
(involves: C57BL/6 * CBA/J)
increased susceptibility to otitis media J:76189
sinus inflammation J:76189
Dnai1tm1.1Leo/Dnai1tm1.1Leo
Gt(ROSA)26Sortm1(cre/ERT)Nat/Gt(ROSA)26Sor+

(involves: 129 * C57BL/6)
rhinosinusitis J:155730
Dnajc3m1Btlr/Dnajc3m1Btlr
(C57BL/6J-Dnajc3m1Btlr)
increased susceptibility to induced colitis J:265248
Dnase1tm1Tmo/Dnase1+
(involves: 129P2/OlaHsd * C57BL/6)
glomerulonephritis J:62549
kidney inflammation J:62549
Dnase1tm1Tmo/Dnase1tm1Tmo
(involves: 129P2/OlaHsd * C57BL/6)
glomerulonephritis J:62549
kidney inflammation J:62549
Dnase1tm2092.1Arte/Dnase1tm2092.1Arte
(involves: C57BL/6)
glomerulonephritis J:277126
Dnase2atm1Osa/Dnase2atm1Osa
Ifnar1tm1Agt/Ifnar1tm1Agt

(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6)
joint inflammation J:238323, J:114982
rheumatoid arthritis J:238323, J:114982
Dnase2atm1Osa/Dnase2atm2Osa
Tg(Mx1-cre)1Cgn/0

(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6 * CBA)
joint inflammation J:114982
rheumatoid arthritis J:114982
Dock2m1Hsd/Dock2m1Hsd
Siaetm1.2Avrk/Siaetm1.2Avrk

(B6NHsd.Cg-Siaetm1.2Avrk Dock2m1Hsd)
glomerulonephritis J:144035
Dpcd/PollGt(OST280355)Lex/Dpcd/PollGt(OST280355)Lex
(involves: 129S5/SvEvBrd * C57BL/6Brd)
increased susceptibility to otitis media J:185566
Dpp4em1Rba/Dpp4+
(C57BL/6J-Dpp4em1Rba)
lung inflammation J:279834
Dpp4em1Rba/Dpp4em1Rba
(C57BL/6J-Dpp4em1Rba)
lung inflammation J:279834
Dpp4tm1(DPP4)Vlcg/?
(involves: 129S6/SvEvTac * C57BL/6NTac)
interstitial pneumonia J:223728
lung inflammation J:223728
Dpp4tm1(DPP4)Vlcg/?
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NTac)
lung inflammation J:238079
pleuritis J:238079
Dpp4tm1.1(DPP4)Pbmj/Dpp4tm1.1(DPP4)Pbmj
(involves: C57BL/6 * C57BL/6NTac)
lung inflammation J:242025
Drd1tm1Jcd/Drd1tm1Jcd
Drd2tm1Ebo/Drd2+

(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6)
small intestinal inflammation J:91781
Droshatm1Litt/Droshatm1.1Litt
Foxp3tm4(YFP/icre)Ayr/Y

(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)
blood vessel inflammation J:138683
liver inflammation J:138683
lung inflammation J:138683
Droshatm1Litt/Droshatm1.1Litt
Foxp3tm4(YFP/icre)Ayr/Foxp3tm4(YFP/icre)Ayr

(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)
blood vessel inflammation J:138683
liver inflammation J:138683
lung inflammation J:138683
Droshatm1Litt/Droshatm1.1Litt
Tg(Cd4-cre)1Cwi/0

(involves: 129P2/OlaHsd * C57BL/6 * DBA/2 * FVB/N)
intestinal inflammation J:138683
liver inflammation J:138683
lung inflammation J:138683
Dsc1tm1Dga/Dsc1tm1Dga
(involves: C57BL/6J)
dermatitis J:73102
Dsg2m1Btlr/Dsg2m1Btlr
(C57BL/6J-Dsg2m1Btlr)
increased susceptibility to induced colitis J:271975
Dsg2m2Btlr/Dsg2m2Btlr
(C57BL/6J-Dsg2m2Btlr)
increased susceptibility to induced colitis J:271976
Dsg2m3Btlr/Dsg2m3Btlr
(C57BL/6J-Dsg2m3Btlr)
increased susceptibility to induced colitis J:271977
Dsg2tm1d(EUCOMM)Wtsi/Dsg2tm1d(EUCOMM)Wtsi
(involves: C57BL/6J * C57BL/6N)
heart inflammation J:235770
Dsg2tm3.1Leu/Dsg2tm3.1Leu
Tg(Vil1-cre)20Syr/0

(involves: 129S7/SvEvBrd * C57BL/6 * DBA/2)
increased susceptibility to colitis induced morbidity/mortality J:302333
increased susceptibility to induced colitis J:302333
Dsg3sqk/Dsg3sqk
(C57BL/6-Dsg3sqk)
conjunctivitis J:219200
Dsg3tm1Stan/Dsg3tm1Stan
(involves: 129X1/SvJ * C57BL/6J)
conjunctivitis J:40804
Dsg4lah-J/Dsg4lah-J
(involves: DBA/1LacJ)
dermatitis J:83117
Dsg4lah/Dsg4lah
(LAH/Pas)
dermatitis J:33849
Dspptm1Kul/Dspptm1Kul
(B6;129-Dspptm1Kul/Mmnc)
periodontium inflammation J:241990
Dssc1C3H/HeJ/Dssc1C57BL/6J
(involves: C3H/HeJ * C57BL/6J)
colitis J:52852
Dssc1C57BL/6J/Dssc1C57BL/6J
(involves: C3H/HeJ * C57BL/6J)
colitis J:52852
Dssc2C3H/HeJ/Dssc2C3H/HeJ
(involves: C3H/HeJ * C57BL/6J)
colitis J:52852
Dssc2C3H/HeJ/Dssc2C57BL/6J
(involves: C3H/HeJ * C57BL/6J)
colitis J:52852
DstTg4/DstTg4
(involves: C57BL/6 * CD-1)
conjunctivitis J:209161
Dtx1tm1.2Mzl/Dtx1tm1.2Mzl
(B6.129-Dtx1tm1.2Mzl)
glomerulonephritis J:151605
liver inflammation J:151605
lung inflammation J:151605
Dusp1tm1Brv/Dusp1tm1Brv
(involves: 129S2/SvPas)
lung inflammation J:118832
Dusp1tm1Brv/Dusp1tm1Brv
(involves: 129S2/SvPas * C57BL/6)
increased susceptibility to endotoxin shock J:118833
Dusp1tm1Brv/Dusp1tm1Brv
(involves: 129S2/SvPas * various)
increased susceptibility to type I hypersensitivity reaction J:125919
Dusp1tm1Brv/Dusp1tm1Brv
(C3.129S2-Dusp1tm1Brv)
lung inflammation J:164929
Dusp1tm1Lex/Dusp1tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
increased susceptibility to endotoxin shock J:126383
increased susceptibility to induced arthritis J:126383
Dusp2tm1Cmac/Dusp2tm1Cmac
(B6.Cg-Dusp2tm1Cmac)
decreased susceptibility to induced arthritis J:112609
Dusp10tm1Flv/Dusp10tm1Flv
(involves: 129S6/SvEvTac)
increased susceptibility to type I hypersensitivity reaction J:92104
Dusp11Gt(BB0198)Wtsi/Dusp11Gt(BB0198)Wtsi
(B6.129P2-Dusp11Gt(BB0198)Wtsi)
increased susceptibility to endotoxin shock J:301503
Dusp22tm1Tht/Dusp22tm1Tht
(B6.129S7-Dusp22tm1Tht)
increased inflammatory response J:213253
kidney inflammation J:213253
liver inflammation J:213253
lung inflammation J:213253
Dysfim/Dysf+
Large1myd/Large1myd

(involves: C57BL/6 * SJL/J)
myositis J:221523
Dysfim/Dysfim
Fktntm1Ttd/Fktntm2(FCMD)Ttd

(involves: 129S7/SvEvBrd * C57BL/6 * SJL/J)
myositis J:221523
Dysfim/Dysfim
Large1myd/Large1myd

(involves: C57BL/6 * SJL/J)
myositis J:221523
Dysftm1Kcam/Dysftm1Kcam
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
myositis J:171870
E2f1tm1Meg/E2f1tm1Meg
(NOD.Cg-E2f1tm1Meg)
insulitis J:93708
salivary gland inflammation J:93708
E2f2tm1Zubi/E2f2tm1Zubi
(involves: 129S1/Sv * C57BL/6)
glomerulonephritis J:76318
increased inflammatory response J:76318
liver inflammation J:76318
lung inflammation J:76318
E2f2tm1Zubi/E2f2tm1Zubi
Tg(TcraH-Y,TcrbH-Y)71Vbo/?

(involves: 129S1/Sv * C57BL/6 * C57BL/6J * DBA/2J)
increased inflammatory response J:76318
E2f3tm1Lees/E2f3tm1Lees
(involves: 129S2/SvPas * C57BL/6)
lung inflammation J:75765
E2f4tm1Lees/E2f4tm1Lees
(involves: 129S2/SvPas * C57BL/6)
increased susceptibility to otitis media J:64193
rhinitis J:64193
Eae2B10.RIII/Eae2RIIIS/J
(involves: B10.RIII * RIIIS/J)
arthritis J:95848
Eae2RIIIS/J/Eae2RIIIS/J
(involves: B10.RIII * RIIIS/J)
decreased susceptibility to induced arthritis J:95848
Eae2bC57BL/10SnSg/Eae2bC57BL/10SnSg
(involves: B10.RIII * RIIIS/J)
CNS inflammation J:96204
Eae7B10.S/DvTe/Eae7B10.S/DvTe
(involves: B10.S/DvTe * SJL/J)
brain inflammation J:49054
Eae7B10.S/DvTe/Eae7SJL/J
(involves: B10.S/DvTe * SJL/J)
brain inflammation J:49054
Eae7SJL/J/Eae7SJL/J
(involves: B10.S/DvTe * SJL/J)
brain inflammation J:49054
Eae16SJL/J/?
(involves: B10.S/DvTe * SJL/J)
increased inflammatory response J:67840
Eae21SJL/J/?
(involves: B10.S/DvTe * SJL/J)
increased inflammatory response J:67840
Eae22SJL/J/?
(involves: B10.S/DvTe * SJL/J)
increased inflammatory response J:67840
Eae23SJL/J/?
(involves: B10.S/DvTe * SJL/J)
increased inflammatory response J:67840
Eae25SJL/J/?
(involves: B10.S/DvTe * SJL/J)
increased inflammatory response J:69083
Eae27C57BL/10SnSg/Eae27RIIIS/J
(involves: B10.RIII * RIIIS/J)
CNS inflammation J:96204
Eae27RIIIS/J/Eae27RIIIS/J
(involves: B10.RIII * RIIIS/J)
CNS inflammation J:96204
Eae39C57BL/10SnSg/Eae39RIIIS/J
(involves: B10.RIII * RIIIS/J)
CNS inflammation J:96204
Eae39RIIIS/J/Eae39RIIIS/J
(involves: B10.RIII * RIIIS/J)
CNS inflammation J:96204
Eae41C57BL/10SnSg/Eae41C57BL/10SnSg
(involves: B10.RIII * RIIIS/J)
CNS inflammation J:96204
Eae44aB10.S/DvTe/Eae44aSJL/J
(involves: B10.S/DvTe * SJL/J)
brain inflammation J:49054
Eae44aSJL/J/Eae44aSJL/J
(involves: B10.S/DvTe * SJL/J)
brain inflammation J:49054
Eaf1tm1.1Zhow/Eaf1tm1.1Zhow
Eaf2tm1Zhow/Eaf2tm1Zhow
Tg(Pbsn-cre)4Prb/0

(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6J * DBA/2)
prostate gland inflammation J:288972
Eaf1tm1.1Zhow/Eaf1tm1.1Zhow
Tg(Pbsn-cre)4Prb/0

(B6(Cg)-Eaf1tm1.1Zhow Tg(Pbsn-cre)4Prb)
prostate gland inflammation J:288972
Eaf2tm1Zhow/Eaf2tm1Zhow
(involves: 129P2/OlaHsd)
prostate gland inflammation J:288972
Eamcd1A/WySn/Eamcd1A/WySn
(B10.A-(D1Mit65-D1Mit334))
myocarditis J:145043
Eamcd2A/WySn/Eamcd2A/WySn
(involves: A.SW-H2s/J * B10.S-H2s/J)
myocarditis J:96562
Ebi3Gt716Lex/Ebi3Gt716Lex
(involves: 129S5/SvEvBrd * C57BL/6)
brain inflammation J:286951
Ebi3tm1Rsb/Ebi3tm1Rsb
(involves: 129X1/SvJ * C57BL/6)
decreased susceptibility to induced colitis J:81014
Ecm1tm1Bsun/Ecm1tm1Bsun
(involves: 129 * C57BL/6)
decreased susceptibility to type I hypersensitivity reaction J:168252
EdaTa-6J/Y
(C57BL/6J Aw-J-EdaTa-6J/J)
blepharitis J:99510
conjunctivitis J:99510
corneal limbitis J:99510
eye inflammation J:99510
increased incidence of corneal inflammation J:99510
Edil3Tg(lacZ)1Tq/Edil3Tg(lacZ)1Tq
(Not Specified)
increased susceptibility to induced arthritis J:254384
Ednrbtm1Nrd/Ednrbtm1Nrd
Gt(ROSA)26Sortm14(CAG-tdTomato)Hze/Gt(ROSA)26Sor+
H2az2Tg(Wnt1-cre)11Rth/0

(involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6 * CBA/J)
large intestinal inflammation J:233811
Ednrbtm1Ywa/Ednrb+
(involves: 129S/SvEvBrd)
decreased acute inflammation J:103977
Ednrbtm1Ywa/Ednrbtm1Ywa
(involves: 129S5/SvEvBrd)
decreased acute inflammation J:103977
Eef1a2wst/Eef1a2wst
(B6C3Fe a/a-Eef1a2wst/J)
decreased susceptibility to type IV hypersensitivity reaction J:6766
Efstm1Kale/Efs+
(either: (involves: 129X1/SvJ) or (involves: 129X1/SvJ * C57BL/6J))
increased inflammatory response J:103757
small intestinal inflammation J:103757
Efstm1Kale/Efstm1Kale
(either: (involves: 129X1/SvJ) or (involves: 129X1/SvJ * C57BL/6J))
increased inflammatory response J:103757
kidney inflammation J:103757
liver inflammation J:103757
lung inflammation J:103757
small intestinal inflammation J:103757
Egfrtm1Dwt/Egfrtm1Dwt
Sox9tm3(cre)Crm/Sox9+

(involves: 129S6/SvEvTac * 129S7/SvEvBrd)
dermatitis J:229771
Egr1tm1Jmi/Egr1tm1Jmi
(B6.129-Egr1tm1Jmi)
liver inflammation J:128421
Egr1tm1Jmi/Egr1tm1Jmi
(involves: 129 * C57BL/6)
decreased inflammatory response J:152898
Egr1tm1Jmi/Egr1tm1Jmi
Tg(Scgb1a1-rtTA,-tTS,tetO-TGFB1*)1Eli/?

(involves: 129 * C57BL/6)
lung inflammation J:92469
Eif2ak2tm1Cwe/Eif2ak2tm1Cwe
(involves: 129S/SvEv * C57BL/6)
increased susceptibility to type IV hypersensitivity reaction J:66112
Eif2ak3tm1.1Drc/Eif2ak3tm1.1Drc
Tg(Ela1-cre)16Eps/0

(involves: 129S6/SvEvTac)
acute pancreas inflammation J:129974
Eif4btm1.1Smoc/Eif4btm1.1Smoc
Ndor1Tg(UBC-cre/ERT2)1Ejb/Ndor1+

(involves: 129 * C57BL/6)
increased susceptibility to induced colitis J:311140
lung inflammation J:311140
Elanetm1Sds/Elanetm1Sds
(involves: 129X1/SvJ * C57BL/6)
abnormal inflammatory response J:113463
Elavl1tm1.1Dkon/Elavl1tm1.1Dkon
Lyz2tm1(cre)Ifo/Lyz2+

(B6.129P2-Elavl1tm1.1Dkon Lyz2tm1(cre)Ifo)
increased susceptibility to endotoxin shock J:184388
increased susceptibility to induced colitis J:184388
Elavl1tm1.1Dkon/Elavl1tm1.1Dkon
Lyz2tm1(cre)Ifo/Lyz2+

(involves: 129P2/OlaHsd * C57BL/6J)
increased susceptibility to endotoxin shock J:184388
Elavl1tm1Lix/Elavl1tm1Lix
Tg(Scgb1a1-rtTA)2Jaw/0
Tg(tetO-cre)1Jaw/0

(involves: 129 * C57BL/6)
decreased inflammatory response J:204952
lung inflammation J:204952
Elf4tm1Nim/Elf4tm1Nim
(B6.129S1-Elf4tm1Nim)
abnormal inflammatory response J:79568
Elovl3tm1Jaco/Elovl3tm1Jaco
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
dermatitis J:88477
Elp1tm1Id/Elp1tm1.1Id
Tg(Hsp70-1-cre)6Arge/0

(involves: 129S1/Sv * C57BL/6 * C57BL/6J * CBA)
conjunctivitis J:188923
Elp1tm1Id/Elp1tm1Id
Tg(Hsp70-1-cre)6Arge/0

(involves: 129S1/Sv * C57BL/6 * C57BL/6J * CBA)
conjunctivitis J:188923
Enpp1asj/Enpp1asj
(C57BL/6J-Enpp1asj/GrsrJ)
increased susceptibility to otitis media J:251638
joint inflammation J:174912
osteoarthritis J:174912
osteomyelitis J:174912
Enpp1ttw/Enpp1ttw
(involves: ICR)
osteoarthritis J:19124, J:37369
Enpp2tm1Lex/Enpp2+
(involves: 129S/SvEvBrd * C57BL/6J)
decreased susceptibility to endotoxin shock J:103485
Enpp3tm1Ktak/Enpp3tm1Ktak
(either: (involves: 129S4/SvJae * C57BL/6) or (involves: 129S4/SvJae * BALB/c * C57BL/6))
increased susceptibility to type I hypersensitivity reaction J:223825
intestinal inflammation J:223825
lung inflammation J:223825
Entpd5tm1Rre/Entpd5tm1Rre
(involves: 129S5/SvEvBrd * C57BL/6J)
liver inflammation J:163795
Epcamtm1.1Mcu/Epcamtm1.1Mcu
Tg(CD207-cre)1Dhka/0

(involves: 129 * C57BL/6 * C57BL/6J * SJL/J)
increased susceptibility to type IV hypersensitivity reaction J:182665
Epcamtm1.2Msiv/Epcamtm1.2Msiv
(involves: C57BL/6 * FVB/N * SJL)
small intestinal inflammation J:210901
Epha1tm1Sld/Epha1tm1Sld
(involves: 129 * C57BL/6J)
endometrium inflammation J:142722
vaginal inflammation J:142722
Ephb6tm1Jwu/Ephb6tm1Jwu
(involves: 129)
decreased susceptibility to type IV hypersensitivity reaction J:94701
Epm2aTg(TcraK,TcrbK)TG-BFlv/Epm2a+
Tg(Ela1-TAg)18Bri/0

(involves: C57BL/6 * CBA/J * SJL)
pancreas inflammation J:107545
Eps15tm1a(KOMP)Wtsi/Eps15tm1a(KOMP)Wtsi
(involves: C57BL/6 * C57BL/6N)
dermatitis J:213427
Epyctm1Mhok/Epyctm1Mhok
(involves: 129S7/SvEvBrd * C57BL/6J)
osteoarthritis J:222369
Erbb3tm1.1Dwt/Erbb3tm2.1Dwt
Tg(Vil1-cre)997Gum/0

(involves: 129S6/SvEvTac * C57BL/6 * SJL)
increased susceptibility to induced colitis J:152703
Erbb4tm1Grl/Erbb4tm1Grl
Tg(Myh6-ERBB4)HT2Gass/0

(involves: 129S1/Sv * 129X1/SvJ)
lung inflammation J:132190
Eregtm1Dwt/Eregtm1Dwt
(129S6/SvEvTac-Eregtm1Dwt)
increased susceptibility to induced colitis J:93327
Eregtm1Sawa/Eregtm1Sawa
(involves: 129X1/SvJ * C57BL/6J)
dermatitis J:92618
Ergtm1.1Iwamo/Ergtm1.1Iwamo
Tg(Gdf5-cre-ALPP)1Kng/?

(involves: 129S4/SvJaeSor * C57BL/6 * FVB/N)
increased susceptibility to induced arthritis J:243715
osteoarthritis J:243715
Ern1tm2.1Tiw/Ern1tm2.1Tiw
Xbp1tm2Glm/Xbp1tm2Glm
Tg(Vil1-cre)997Gum/0

(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * SJL)
small intestinal inflammation J:206084
Ern2m1Btlr/Ern2m1Btlr
(C57BL/6J-Ern2m1Btlr)
increased susceptibility to induced colitis J:216045
Ern2M2Btlr/Ern2M2Btlr
(C57BL/6J-Ern2M2Btlr)
increased susceptibility to induced colitis J:234237
Ern2m3Btlr/Ern2m3Btlr
(C57BL/6J-Ern2m3Btlr)
increased susceptibility to induced colitis J:236686
Ern2tm1Dron/Ern2tm1Dron
(either: 129S6/SvEvTac-Ern2tm1Dron or B6.129S6-Ern2tm1Dron)
increased susceptibility to induced colitis J:67934
Errfi1tm1Gvw/Errfi1tm1Gvw
(Not Specified)
accelerated temporomandibular joint osteoarthritis J:100927
osteoarthritis J:100927
Errfi1tm1Gvw/Errfi1tm1Gvw
Rag2tm1Fwa/Rag2tm1Fwa

(involves: 129S/SvEv)
osteoarthritis J:100927
Errfi1tm3.1Gvw/Errfi1tm3.1Gvw
Tg(CMV-cre)1Cgn/0

(involves: 129 * 129S4/SvJaeSor * BALB/cJ)
osteoarthritis J:206807
Errfi1tm3.1Gvw/Errfi1tm3.1Gvw
Tg(Col2a1-cre)1Asz/0

(involves: 129S1/Sv * 129S4/SvJaeSor * C57BL/6 * CBA)
osteoarthritis J:206807
Esr1tm1Ksk/Esr1tm1Ksk
(involves: 129P2/OlaHsd * C57BL/6J)
glomerulonephritis J:88156
Esr1tm1Ksk/Esr1tm1Ksk
(involves: 129P2/OlaHsd)
spermatic granuloma J:60490
Esr1tm1Ksk/Esr1tm1Ksk
Inhatm1Bay/Inhatm1Bay

(involves: 129P2/OlaHsd * 129S6/SvEvTac * 129S7/SvEvBrd)
liver inflammation J:84989
Esr2tm1Unc/Esr2tm1Unc
(involves: 129P2/OlaHsd)
colitis J:107308
urinary bladder inflammation J:122274
exf/exf
(involves: C3H/HeN(MTV-))
conjunctivitis J:5649
Exph5tm1Tiz/Exph5tm1Tiz
(B6NJcl.Cg-Exph5tm1Tiz/Tiz)
increased susceptibility to type I hypersensitivity reaction J:313415
Eya4tm1Jse/Eya4tm1Jse
(involves: 129S6/SvEvTac * CBA/J)
increased susceptibility to otitis media J:131873
F2tm2Jld/F2+
(B6.129P2-F2tm2Jld)
decreased susceptibility to endotoxin shock J:174629
F2tm2Jld/F2+
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2J)
decreased susceptibility to induced arthritis J:174629
F2rtm1Ajc/F2rtm1Ajc
F2rl1tm1Cgh/F2rl1tm1Cgh

(involves: 129S4/SvJae * C57BL/6)
increased susceptibility to endotoxin shock J:132733
F2rtm1Pago/F2rtm1Pago
(involves: 129P2/OlaHsd * C57BL/6)
decreased inflammatory response J:124648
decreased susceptibility to induced colitis J:94420
F2rtm1Pago/F2rtm1Pago
(involves: 129P2/OlaHsd)
decreased susceptibility to endotoxin shock J:133917
F2rl1tm1Bpd/F2rl1tm1Bpd
(involves: 129P2/OlaHsd * C57BL/6)
decreased inflammatory response J:124648
increased inflammatory response J:96196
increased susceptibility to induced pancreatitis J:96196
F2rl1tm1Bpd/F2rl1tm1Bpd
(B6.129P2-F2rl1tm1Bpd)
decreased susceptibility to endotoxin shock J:88245
F2rl1tm1Cgh/F2rl1tm1Cgh
(involves: 129S4/SvJae * C57BL/6)
glomerulonephritis J:124303
F2rl1tm1Jkaw/F2rl1tm1Jkaw
(involves: 129P2/OlaHsd * C57BL/6)
decreased susceptibility to type IV hypersensitivity reaction J:106127
F2rl1tm1Mslb/F2rl1tm1Mslb
(involves: 129X1/SvJ * C57BL/6)
decreased inflammatory response J:79757
F2rl1tm1Wrf/F2rl1tm1Wrf
(involves: 129P2/OlaHsd * C57BL/6)
decreased susceptibility to induced arthritis J:81119
F2rl1tm1Wrf/F2rl1tm1Wrf
(involves: 129P2/OlaHsd)
liver inflammation J:102762
F3tm1.1Dwr/F3tm1.1Dwr
(involves: 129S1/Sv * 129X1/SvJ * MF1 * Swiss)
decreased susceptibility to endotoxin shock J:91165
F3tm1Dco/F3tm1Dco
Tg(F3)1Nmk/0

(B6.Cg-F3tm1Dco Tg(F3)1Nmk)
decreased susceptibility to endotoxin shock J:88245
F11tm1Gjb/F11tm1Gjb
Proctm1Fjc/Proctm1Fjc

(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
lung inflammation J:67398
F11rtm1.1Dej/F11rtm1.1Dej
(Not Specified)
increased susceptibility to type IV hypersensitivity reaction J:92592
Faddtm1Mpa/Faddtm1Mpa
Ikbkgtm1.1Mpa/Ikbkgtm1.1Mpa
Tg(Alb1-cre)7Gsc/0

(involves: C57BL/6 * FVB/N)
liver inflammation J:118336
Faddtm1Mpa/Faddtm1Mpa
Myd88tm1Aki/Myd88tm1Aki
Tg(Vil1-cre)997Gum/0

(B6.Cg-Faddtm1Mpa Myd88tm1Aki Tg(Vil1-cre)997Gum)
cecum inflammation J:175865
Faddtm1Mpa/Faddtm1Mpa
Tg(Vil1-cre)997Gum/0

(B6.Cg-Faddtm1Mpa Tg(Vil1-cre)997Gum)
cecum inflammation J:175865
colitis J:175865
Faddtm1Mpa/Faddtm1Mpa
Tnftm1Gkl/Tnftm1Gkl
Tg(Vil1-cre)997Gum/0

(B6.Cg-Faddtm1Mpa Tnftm1Gkl Tg(Vil1-cre)997Gum)
cecum inflammation J:175865
colitis J:175865
Fads2tm1Mtna/Fads2tm1Mtna
(involves: 129S6/SvEvTac * C57BL/6J)
dermatitis J:153293
Fahtm1Mgo/Fahtm1Mgo
(involves: 129S7/SvEvBrd * PT)
kidney inflammation J:77295
Fahtm1Mgo/Fahtm1Mgo
(involves: 129S7/SvEvBrd * C57BL)
liver inflammation J:27735
Fahtm1Mgo/Fahtm1Mgo
Hgdaku/Hgd+

(involves: 129S7/SvEvBrd * NB)
kidney inflammation J:77295
Faimtm1Kplm/Faimtm1Kplm
(involves: 129P2/OlaHsd * C57BL/6)
liver inflammation J:164184
Fam3dem1Wko/Fam3dem1Wko
(C57BL/6-Fam3dem1Wko)
colitis J:300819
increased susceptibility to colitis induced morbidity/mortality J:300819
increased susceptibility to induced colitis J:300819
Fam13atm1e(KOMP)Wtsi/Fam13atm1e(KOMP)Wtsi
(C57BL/6N-Fam13atm1e(KOMP)Wtsi)
adipose tissue inflammation J:258290
Fam20ctm1.1Cqi/Fam20ctm1.1Cqi
Tg(Col1a1-cre)2Bek/0

(involves: 129S6/SvEvTac * CD-1)
dental pulp inflammation J:225679
periodontium inflammation J:225679
Fan1tm1a(KOMP)Wtsi/Fan1tm1a(KOMP)Wtsi
(129S1.B6-Fan1tm1a(KOMP)Wtsi)
tubulointerstitial nephritis J:242198
Faslpr/Fas+
Tg(TcraTcrb)1100Mjb/?

(involves: C57BL/6 * MRL/Mp)
liver inflammation J:72817
Faslpr/Faslpr
(MRL/Mp-Faslpr)
abnormal type III hypersensitivity reaction J:28885
blood vessel inflammation J:28885
glomerulonephritis J:27634, J:13757, J:28885
lacrimal gland inflammation J:18512
salivary gland inflammation J:18512
submandibular gland inflammation J:21965
thyroid gland inflammation J:28171
Faslpr/Faslpr
(MRL/MpJ-Faslpr/J)
CNS inflammation J:14151
conjunctivitis J:123192
glomerulonephritis J:92084, J:122315, J:127199, J:7454
salivary gland inflammation J:92084
Faslpr/Faslpr
(involves: C3H * MRL/Mp)
increased susceptibility to type III hypersensitivity reaction J:34296
Faslpr/Faslpr
(B6.MRL-Faslpr/J)
brain inflammation J:120427
CNS inflammation J:120427
Faslpr/Faslpr
(MRL-Faslpr)
glomerulonephritis J:126261
Faslpr/Faslpr
(MRL.Cg-Irf1tm1Mak Faslpr)
glomerulonephritis J:114771
Faslpr/Faslpr
(C3.MRL-Faslpr/J)
glomerulonephritis J:7454
Faslpr/Faslpr
(B6.MRL-Faslpr)
glomerulonephritis J:135036, J:7454
Faslpr/Faslpr
(AK.MRL-Faslpr)
glomerulonephritis J:7454
Faslpr/Faslpr
(C3.MRL-Faslpr)
lacrimal gland inflammation J:1028
salivary gland inflammation J:1028
Faslpr/Faslpr
(MRL/MpJ-Faslpr)
blood vessel inflammation J:137066
glomerulonephritis J:125114, J:132514, J:137066
Faslpr/Faslpr
(involves: 129P2/OlaHsd * MRL)
glomerulonephritis J:45448
kidney inflammation J:45448
Faslpr/Faslpr
Fcer1gtm1Tks/Fcer1gtm1Tks

(MRL.Cg-Fcer1gtm1Tks Faslpr)
arteritis J:106188
decreased susceptibility to type III hypersensitivity reaction J:106188
glomerulonephritis J:106188
Faslpr/Faslpr
Ifnar1tm1Agt/Ifnar1tm1Agt

(MRL.Cg-Ifnar1tm1Agt Faslpr)
glomerulonephritis J:92084
salivary gland inflammation J:92084
Faslpr/Faslpr
Ifnar1tm1Agt/Ifnar1tm1Agt
Ifngr1tm1Agt/Ifngr1tm1Agt

(MRL.Cg-Ifngr1tm1Agt Ifnar1tm1Agt Faslpr)
glomerulonephritis J:92084
salivary gland inflammation J:92084
Faslpr/Faslpr
Ifngtm1Ts/Ifng+

(MRL.Cg-Ifngtm1Ts Faslpr)
glomerulonephritis J:123834
Faslpr/Faslpr
Ifngtm1Ts/Ifngtm1Ts

(MRL.Cg-Ifngtm1Ts Faslpr)
kidney inflammation J:123834
lung inflammation J:123834
Faslpr/Faslpr
Ifngr1tm1Agt/Ifngr1tm1Agt

(MRL.Cg-Ifngr1tm1Agt Faslpr)
glomerulonephritis J:92084
Faslpr/Faslpr
Il4tm1Cgn/Il4tm1Cgn

(MRL.Cg-Il4tm1Cgn Faslpr)
glomerulonephritis J:132514
lacrimal gland inflammation J:132514
Faslpr/Faslpr
Il27ratm1Mak/Il27ratm1Mak

(MRL.Cg-Il27ratm1Mak Faslpr)
glomerulonephritis J:122148
Faslpr/Faslpr
Irf1tm1Mak/Irf1+

(MRL.Cg-Irf1tm1Mak Faslpr)
glomerulonephritis J:114771
Faslpr/Faslpr
Irf1tm1Mak/Irf1tm1Mak

(MRL.Cg-Irf1tm1Mak Faslpr)
glomerulonephritis J:114771
Faslpr/Faslpr
Selptm1Bay/Selptm1Bay

(MRL.Cg-Selptm1Bay Faslpr)
dermatitis J:127199
glomerulonephritis J:127199
Faslpr/Faslpr
Selplgtm1Fur/Selplgtm1Fur

(MRL.Cg-Selplgtm1Fur Faslpr)
dermatitis J:127199
glomerulonephritis J:127199
Faslpr/Faslpr
Spp1tm1Rit/Spp1tm1Rit

(involves: 129S7/SvEvBrd * C57BL/6 * MRL/Mp)
kidney inflammation J:73396
Faslpr/Faslpr
Tcratm1Mjo/Tcratm1Mjo

(involves: 129P2/OlaHsd * MRL)
kidney inflammation J:45448
Faslpr/Faslpr
Tg(CD2-Foxj1)#Stlp/0

(MRL.Cg-Faslpr Tg(CD2-Foxj1)#Stlp)
kidney inflammation J:122222
liver inflammation J:122222
lung inflammation J:122222
salivary gland inflammation J:122222
Faslpr/Faslpr
Tg(INS-Il10)#Sar/0

(NOD.Cg-Faslpr Tg(INS-Il10)#Sar)
insulitis J:64051
Faslpr/Faslpr
Tlr9tm1Aki/Tlr9tm1Aki

(B6.Cg-Tlr9tm1Aki Faslpr)
glomerulonephritis J:135036
Faslpr/Faslpr
Tlr9tm1Aki/Tlr9tm1Aki

(MRL.Cg-Tlr9tm1Aki Faslpr)
glomerulonephritis J:113557
kidney inflammation J:113557
Faslpr/Faslpr
Tnfrsf1atm1.1Gkl/Tnfrsf1atm1.1Gkl

(involves: 129/Sv * C57BL/6)
liver inflammation J:92470
Faslpr/Faslpr
Tnfrsf9tm1Byk/Tnfrsf9tm1Byk

(MRL.Cg-Tnfrsf9tm1Byk Faslpr)
lacrimal gland inflammation J:126929
Fastm1Cgn/Fastm1Cgn
Tg(Cd4-cre)1Cwi/0

(B6.Cg-Tg(Cd4-cre)1Cwi Fastm1Cgn)
alveolitis J:114948
increased inflammatory response J:114948
kidney inflammation J:114948
liver inflammation J:114948
lung inflammation J:114948
Faslgld/Faslgld
(C3H/HeJ-Faslgld/J)
interstitial pneumonia J:7306
Faslgld/Faslgld
(B6Smn.C3-Faslgld/J)
brain inflammation J:120427
CNS inflammation J:120427
eye inflammation J:136745
liver inflammation J:135830
Faslgld/Faslgld
(involves: C3H/HeJ * C57BL/6)
dermatitis J:153501
Fasltm1.1Ast/Fasltm1.1Ast
(involves: BALB/cJ * C57BL/6)
dermatitis J:153501
glomerulonephritis J:153501
Fasltm1.1Lest/Fasltm1.1Lest
(involves: 129 * C57BL/6)
glomerulonephritis J:87990
Fasltm1.1Lest/Fasltm1.1Lest
(B6.129-Fasltm1.1Lest)
glomerulonephritis J:87990
Fat1Gt(KST249)Byg/Fat1Gt(KST249)Byg
Tg(Myl1-lacZ)1Ibdml/0

(involves: 129P2/OlaHsd)
myositis J:199157
Fat1tm1.2Fhel/Fat1tm1.2Fhel
Tg(Myl1-lacZ)1Ibdml/0

(involves: 129S6/SvEvTac * BALB/cJ * C57BL/6J * SJL)
myositis J:199157
Fbn1tm1Lper/Fbn1+
(involves: 129/Sv * CD-1)
lung inflammation J:167276
Fbn1tm2Rmz/Fbn1tm2Rmz
(involves: 129S1/Sv * 129X1/SvJ)
aortitis J:54081
lung inflammation J:91815
Fbn1Tsk/Fbn1+
(B6.Cg-Fbn1Tsk)
alveolitis J:15018, J:30961, J:6566
increased susceptibility to type IV hypersensitivity reaction J:7185
lung inflammation J:30961, J:6566
Fbxl4tm1.2Lrsn/Fbxl4tm1.2Lrsn
(involves: C57BL/6N)
liver inflammation J:303084
Fbxl5tm2.1Kei/Fbxl5tm2.1Kei
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+

(involves: C57BL/6 * DBA)
liver inflammation J:176655
Fbxo11Jf/Fbxo11+
(involves: BALB/cAnNCrl * C3H/HeN)
increased susceptibility to otitis media J:85263
Fbxo11Jf/Fbxo11+
(involves: BALB/cAnNCrl * C3H/HeN * C57BL/6J)
increased susceptibility to otitis media J:114851
Fbxo11Jf/Fbxo11+
(involves: BALB/cAnNCrl)
increased susceptibility to otitis media J:250208
Fbxo11Jf/Fbxo11Mutt
(involves: BALB/c * C3H/HeN)
increased susceptibility to otitis media J:114851
Fcer1atm1Knt/Fcer1atm1Knt
(either: (involves: 129 * C57BL/6) or (involves: 129 * C57BL/6 * DBA/2))
decreased susceptibility to type I hypersensitivity reaction J:113572, J:39250
Fcer1atm1Knt/Fcer1atm1Knt
(involves: 129 * BALB/c)
increased susceptibility to type I hypersensitivity reaction J:78659
Fcer1atm1Knt/Fcer1atm1Knt
Fcer2atm1Max/Fcer2atm1Max
Fcgr1tm1Jsv/Fcgr1tm1Jsv
Fcgr2btm1Ttk/Fcgr2btm1Ttk
Fcgr3tm1Jsv/Fcgr3tm1Jsv

(B6.Cg-Fcgr2btm1Ttk Fcgr3tm1Jsv Fcer1atm1Knt Fcgr1tm1Jsv Fcer2atm1Max)
increased susceptibility to type I hypersensitivity reaction J:144620
Fcer1atm1Knt/Fcer1atm1Knt
Tg(SV40/HTLV-FCER1A)1Bhk/0

(either: (involves: 129 * C57BL/6) or (involves: 129 * C57BL/6 * DBA/2))
abnormal type I hypersensitivity reaction J:113572
Fcer1gtm1Rav/Fcer1gtm1Rav
(involves: 129P2/OlaHsd * C57BL/6)
decreased susceptibility to type I hypersensitivity reaction J:78659, J:39248
Fcer1gtm1Tks/Fcer1gtm1Tks
(involves: C57BL/6)
decreased inflammatory response J:50023
decreased susceptibility to type IV hypersensitivity reaction J:112160
Fcer2atm1Max/Fcer2atm1Max
(involves: C57BL/6)
increased susceptibility to type I hypersensitivity reaction J:57738
Fcer2atm1Max/Fcer2atm1Max
Ighg1tm1.1Pyu/Ighg1+

(involves: 129 * BALB/cJ * C57BL/6 * C57BL/6J)
increased susceptibility to type I hypersensitivity reaction J:198154
Fcer2atm1Max/Fcer2atm1Max
Ighg1tm1.1Pyu/Ighg1tm1.1Pyu

(involves: 129 * BALB/cJ * C57BL/6 * C57BL/6J)
increased susceptibility to type I hypersensitivity reaction J:198154
Fcgr1tm1Hoga/Fcgr1tm1Hoga
(involves: 129S1/Sv * 129X1/SvJ)
decreased inflammatory response J:86281
Fcgr1tm1Jsv/Fcgr1tm1Jsv
(involves: 129P2/OlaHsd * BALB/c)
abnormal type I hypersensitivity reaction J:83995
decreased susceptibility to induced arthritis J:83995
Fcgr2btm1.2Jsv/Fcgr2btm1.2Jsv
Sle16C57BL/6/Sle16C57BL/6

(involves: C57BL/6 * FVB/N)
increased susceptibility to induced arthritis J:179175
kidney inflammation J:179175
Fcgr2btm1Kgcs/Fcgr2b+
(involves: C57BL/6)
increased susceptibility to induced arthritis J:190890
Fcgr2btm1Ttk/Fcgr2btm1Ttk
(involves: 129S4/SvJae)
increased susceptibility to type I hypersensitivity reaction J:31133
Fcgr2btm1Ttk/Fcgr2btm1Ttk
(B6.129S4-Fcgr2btm1Ttk)
glomerulonephritis J:64152
increased inflammatory response J:64152
kidney inflammation J:64152
liver inflammation J:64152
lung inflammation J:64152
pancreas inflammation J:64152
salivary gland inflammation J:64152
Fcgr2btm1Ttk/Fcgr2btm1Ttk
(Not Specified)
increased susceptibility to induced arthritis J:106191
Fcgr2btm1Ttk/Fcgr2btm1Ttk
Il17atm1Yiw/Il17a+

(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
glomerulonephritis J:191090
kidney inflammation J:191090
Fcgr2btm1Ttk/Fcgr2btm1Ttk
Pdcd1tm1Hon/Pdcd1tm1Hon

(involves: 129S2/SvPas * 129S4/SvJae * BALB/c)
urinary bladder inflammation J:207275
Fcgr2btm1Ttk/Fcgr2btm1Ttk
Sle21129P2/Ola/Sle21129P2/Ola

(B6.129S4-Fcgr2btm1Ttk)
increased susceptibility to induced arthritis J:179175
kidney inflammation J:179175
Fcgr2btm1Ttk/Fcgr2btm1Ttk
Traf3ip2tm1Sbn/Traf3ip2+

(involves: 129 * 129S4/SvJae * C57BL/6)
kidney inflammation J:191090
Fcgr2btm1Ttk/Fcgr2btm1Ttk
Traf3ip2tm2Sbn/Traf3ip2tm2Sbn
Cd79atm1(cre)Reth/Cd79a+

(involves: 129S4/SvJae * BALB/c * C57BL/6)
glomerulonephritis J:191090
Fcgr3tm1Jsv/Fcgr3tm1Jsv
(involves: 129P2/OlaHsd * C57BL/6)
abnormal type I hypersensitivity reaction J:83995
decreased susceptibility to type II hypersensitivity reaction J:35057
Fcgr3tm1Jsv/Fcgr3tm1Jsv
(B6.129P2-Fcgr3tm1Jsv/J)
decreased susceptibility to induced arthritis J:106191
Fcgr3tm1Ttk/Fcgr3tm1Ttk
(involves: 129X1/SvJ)
decreased susceptibility to type I hypersensitivity reaction J:107371
Fcgr4tm1.1Rav/Fcgr4tm1.1Rav
(involves: C57BL/6)
decreased susceptibility to induced arthritis J:167375
Fcgr4tm1Rav/Fcgr4tm1Rav
Tg(Ctsk-cre)1Rda/0

(involves: C57BL/6)
arthritis J:197378
Fdxrtm1Xch/Fdxr+
(B6.Cg-Fdxrtm1Xch)
chronic liver inflammation J:244082
Fem1atm1Seno/Fem1atm1Seno
(C57BL/6-Fem1atm1Seno)
increased susceptibility to colitis induced morbidity/mortality J:228893
increased susceptibility to induced colitis J:228893
Fen1tm3.1Bhsh/Fen1+
(Not Specified)
chronic inflammation J:231218
glomerulonephritis J:231218
interstitial pneumonia J:231218
lung inflammation J:231218
Fen1tm3.1Bhsh/Fen1tm3.1Bhsh
(Not Specified)
chronic inflammation J:231218
glomerulonephritis J:231218
interstitial pneumonia J:231218
lung inflammation J:231218
Fermt1tm1Ref/Fermt1tm1Ref
(involves: 129S1/Sv * 129X1/SvJ)
ileum inflammation J:142913
large intestinal inflammation J:142913
Festm1Mcs/Festm1Mcs
(involves: 129X1/SvJ)
conjunctivitis J:64748
Festm2Pag/Festm2Pag
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
increased susceptibility to endotoxin shock J:98590
Ffar2tm1Dgen/Ffar2tm1Dgen
(involves: C57BL/6)
increased susceptibility to induced arthritis J:153951
increased susceptibility to induced colitis J:153951
lung inflammation J:153951
Ffar2tm2Lex/Ffar2tm2Lex
(involves: 129S7/SvEvBrd * C57BL/6)
abnormal inflammatory response J:157383
decreased susceptibility to induced colitis J:157383
large intestinal inflammation J:157383
Fgfr1Hspy/Fgfr1+
(C3HeB/FeJ-Hspy)
increased susceptibility to otitis media J:95895
Fgfr1tm1Upir/Fgfr1tm1Upir
Fgfr2tm1Dor/Fgfr2tm1Dor
Tg(KRT5-cre)5132Jlj/0

(involves: 129X1/SvJ * C57BL/6 * C57BL/6J * DBA/2J)
dermatitis J:221184
skin inflammation J:158802, J:221184
Fgfr2tm1Dsn/Fgfr2tm1Dsn
Tg(KRT5-cre)5132Jlj/0

(involves: 129P2/OlaHsd * C57BL/6J * DBA/2J)
adipose tissue inflammation J:119723
skin inflammation J:119723
Fgfr2tm1Ewj/Fgfr2+
Tg(EIIa-cre)C5379Lmgd/0

(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N)
bronchiolectasis J:101174
Fgl1tm1b(EUCOMM)Hmgu/Fgl1tm1b(EUCOMM)Hmgu
(involves: BALB/cJ * C57BL/6N)
dermatitis J:269578
FgrMhdaali18/Fgr+
(C3HeB/FeJ-FgrMhdaali18)
dermatitis J:112868
increased inflammatory response J:112868
FgrMhdaali18/FgrMhdaali18
(C3HeB/FeJ-FgrMhdaali18)
arthritis J:112868
dermatitis J:112868
Fgrtm1Hev/Fgrtm1Hev
(B6.129S7-Fgrtm1Hev)
abnormal inflammatory response J:113463
Fgrtm1Hev/Fgrtm1Hev
Hcktm1Hev/Hcktm1Hev
Lyntm1Sor/Lyntm1Sor

(B6.Cg-Hcktm1Hev Fgrtm1Hev Lyntm1Sor)
abnormal inflammatory response J:113463
Fhip2bem1Wwan/Fhip2bem1Wwan
(involves: C57BL/6)
increased susceptibility to induced colitis J:285283
liver inflammation J:302658
Fignfi/Fignfi
(mixed)
conjunctivitis J:13035
eye inflammation J:13035
Fkbp11Gt(OST298786)Lex/Fkbp11Gt(OST298786)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
increased inflammatory response J:103485
Fkrptm1Scbr/Fkrptm1Scbr
Sox1tm1(cre)Take/Sox1+

(involves: C57BL/6NCrlj * CBA/JNCrlj)
myositis J:207119
Fkrptm1Scbr/Fkrptm1Scbr
Sox1tm1(cre)Take/Sox1+
Tg(CAG-LARGE)126Fmu/0

(involves: C57BL/6NCrlj * C57BL/10 * CBA/Ca * CBA/JNCrlj)
myositis J:207119
Flgft/Flgft
(involves: C57BL/6)
skin inflammation J:151110
Flgft/Flgft
(Not Specified)
dermatitis J:198332
Flgft/Flgft
(STOCK a/a Tmem79ma Flgft/J)
dermatitis J:204304
Flgft/Flgft
Tmem79ma/Tmem79ma

(involves: CBA/CaGr)
blepharitis J:202453
skin inflammation J:202453
Flgtm1Amag/Flgtm1Amag
(involves: 129S6/SvEvTac * BALB/c * C57BL/6NTac)
dermatitis J:198332
increased inflammatory response J:229771
increased susceptibility to type IV hypersensitivity reaction J:198332
Flgtm1Amag/Flgtm1Amag
Tg(CD207-Dta)312Dhka/0

(involves: 129S6/SvEvTac * BALB/c * C57BL/6NTac * FVB)
decreased inflammatory response J:229771
Flicrem1Doi/Flicrem1Doi
(NOD/ShiLtDoi-Flicrem1Doi)
insulitis J:241346
Flvcr2tm1.2Tda/Flvcr2tm1.2Tda
(involves: C57BL/6J)
brain inflammation J:287134
Fmodtm1Aol/Fmodtm1Aol
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
osteoarthritis J:79115
Fmodtm1Aol/Fmodtm1Aol
Lumtm1Chak/Lumtm1Chak

(involves: 129S1/Sv * 129X1/SvJ * CD-1)
osteoarthritis J:79115
Fndc4tm1.1Mabo/Fndc4tm1.1Mabo
(involves: C57BL/6 * BALB/c)
increased susceptibility to induced colitis J:236896
Fostm3.1Wag/Fostm3.1Wag
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
increased susceptibility to endotoxin shock J:175064
Fostm4.1Wag/Fostm4.1Wag
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
increased susceptibility to endotoxin shock J:175064
Fostm5.1Wag/Fostm5.1Wag
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
increased susceptibility to endotoxin shock J:175064
Fostm6.1Wag/Fostm6.1Wag
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
increased susceptibility to endotoxin shock J:175064
Fostm7Wag/Fostm7Wag
Lyz2tm1(cre)Ifo/Lyz2+

(involves: 129P2/OlaHsd * C57BL/6)
increased susceptibility to endotoxin shock J:175064
Foxa2tm1.1Khk/Foxa2+
(involves: 129P2/OlaHsd * C57BL/6 * CD-1)
respiratory system inflammation J:284174
Foxf1em1Vvk/Foxf1+
(involves: C57BL/6 * DBA/2)
lung inflammation J:296328
Foxm1tm1Rhc/Foxm1tm1Rhc
Tg(Tek-cre)1Ywa/0

(involves: 129X1/SvJ * C57BL/6 * SJL)
lung inflammation J:167773
Foxn1nu/Foxn1+
(involves: BALB/c)
blepharitis J:12543
increased incidence of corneal inflammation J:12543
Foxn1nu/Foxn1nu
(involves: BALB/c)
blepharitis J:12543
Foxn1nu/Foxn1nu
Tgfb1tm1Doe/Tgfb1tm1Doe

(involves: 129S2/SvPas * BALB/c * CF-1)
decreased inflammatory response J:99033
Foxo1tm1Flv/Foxo1tm1Flv
Foxp3tm4(YFP/icre)Ayr/Foxp3+

(involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ)
abnormal inflammatory response J:189962
Foxo1tm1Flv/Foxo1tm1Flv
Tg(Cd4-cre)1Cwi/?

(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
increased susceptibility to induced colitis J:147057
Foxo3Gt(XAO26)Byg/Foxo3Gt(XAO26)Byg
(involves: 129P2/OlaHsd)
increased inflammatory response J:93593
kidney inflammation J:93593
lung inflammation J:93593
salivary gland inflammation J:93593
Foxo3tm1.1Rdp/Foxo3tm1.1Rdp
(involves: 129S6/SvEvTac * FVB/N)
dermatitis J:118179
Foxp3sf/Y
(either: 129Rl.Cg-Foxp3sf or (involves: 101/Rl * C3Hf/Rl * STOCK MR))
blepharitis J:11262
dermatitis J:11262
increased inflammatory response J:11262
liver inflammation J:11262
Foxp3sf/Y
(involves: 101/H * C3H/HeH * STOCK MR)
conjunctivitis J:10398
Foxp3sf/?
(Not Specified)
liver inflammation J:138808
lung inflammation J:138808
Foxp3sf/Y
(B6.Cg-Foxp3sf/J)
lung inflammation J:125129
salivary gland inflammation J:125129
skin inflammation J:125129
Foxp3tm1(CD2/CD52)Shori/Foxp3tm1(CD2/CD52)Shori
(involves: C57BL/6)
increased susceptibility to type IV hypersensitivity reaction J:171378
Foxp3tm1(cre)Saka/Y
(involves: BALB/c)
stomach inflammation J:140085
Foxp3tm1.1Ayr/Y
(involves: 129S1/Sv * 129X1/SvJ)
skin inflammation J:82560
Foxp3tm1.1Ayr/Y
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
dermatitis J:117743
liver inflammation J:117743
lung inflammation J:117743
lymph node inflammation J:117743
Foxp3tm1.1Ayr/Foxp3tm1.1Ayr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
dermatitis J:117743
liver inflammation J:117743
lung inflammation J:117743
lymph node inflammation J:117743
Foxp3tm1.1Ayr/Foxp3tm1.1Ayr
Mir146tm1.1Bal/Mir146tm1.1Bal

(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
blepharitis J:167922
conjunctivitis J:167922
dermatitis J:167922
Foxp3tm1Ayr/Y
Tg(Cd4-cre)1Cwi/0

(involves: C57BL/6 * DBA/2)
dermatitis J:97029
Foxp3tm1Tch/Y
(C.129X1-Foxp3tm1Tch)
abnormal inflammatory response J:117165
dermatitis J:117165
respiratory system inflammation J:117165
Foxp3tm1Tch/Y
(B6.129X1-Foxp3tm1Tch)
abnormal inflammatory response J:117165
dermatitis J:117165
respiratory system inflammation J:117165
Foxp3tm2.1(EGFP/cre)Shori/Y
Pdcd1tm1Hon/Pdcd1tm1Hon

(involves: 129 * 129S2/SvPas * C57BL/6)
pancreas inflammation J:234397
Foxp3tm2Flv/Y
(involves: C57BL/6)
blepharitis J:118631
Foxp3tm3(DTR/GFP)Ayr/Foxp3tm3(DTR/GFP)Ayr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
conjunctivitis J:117743
dermatitis J:117743
liver inflammation J:117743
lung inflammation J:117743
lymph node inflammation J:117743
Foxp3tm3Tch/Y
(C.129X1-Foxp3tm3Tch)
colitis J:120636
Foxp3tm4(YFP/icre)Ayr/Foxp3tm4(YFP/icre)Ayr
Ikzf4tm1Djr/Ikzf4tm1Djr

(involves: 129S1/Sv * 129X1/SvJ)
chronic inflammation J:294549
glomerulonephritis J:294549
granulomatous inflammation J:294549
small intestinal inflammation J:294549
Foxq1sa/Foxq1sa
Lystbg/Lystbg

(involves: 101/Rl * C3H/Rl * C57BL/6J * C57BL10/Rl)
interstitial pneumonia J:15166, J:5311
Foxq1sa/Foxq1sa
Lystbg/Lystbg

(involves: 101/Rl * C3H/Rl * C57BL10/Rl)
interstitial pneumonia J:5311
lung inflammation J:5311
Fpr2tm1.1Jimw/Fpr2tm1.1Jimw
Lyz2tm1(cre)Ifo/Lyz2+

(involves: 129P2/OlaHsd * 129X1/SvJ)
decreased susceptibility to induced colitis J:197568
Fpr2tm1.2Jimw/Fpr2tm1.2Jimw
(B6.129X1-Fpr2tm1.2Jimw)
decreased inflammatory response J:160074
Fpr2tm1.2Jimw/Fpr2tm1.2Jimw
(involves: 129X1/SvJ)
colitis J:197568
decreased acute inflammation J:197568
Fpr2tm1Rjf/Fpr2tm1Rjf
(involves: 129S/SvEv * C57BL/6)
increased acute inflammation J:159658
increased susceptibility to induced arthritis J:159658
FrylGt(Ayu21-T312)Imeg/FrylGt(Ayu21-T312)Imeg
(B6J.Cg-FrylGt(Ayu21-T312)Imeg)
kidney inflammation J:260667
Fth1tm1.1Lck/Fth1tm1.1Lck
Tg(Mx1-cre)1Cgn/0

(B6.Cg-Fth1tm1.1Lck Tg(Mx1-cre)1Cgn)
liver inflammation J:166515
Ftotm1.2Pzg/Ftotm1.2Pzg
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6)
dermatitis J:166984
Ftotm1.3Pzg/Ftotm1.3Pzg
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6)
dermatitis J:166984
Fut4tm1Jbl/Fut4tm1Jbl
Fut7tm1Jbl/Fut7tm1Jbl

(B6.129S2-Fut7tm1Jbl Fut4tm1Jbl)
decreased susceptibility to type IV hypersensitivity reaction J:79388
Fut7tm1Jbl/Fut7tm1Jbl
(B6.129S2-Fut7tm1Jbl)
decreased susceptibility to type IV hypersensitivity reaction J:79388, J:74776
Fxntm1Mkn/Fxntm1Mkn
Tg(FXN)YG8Pook/0

(involves: 129/Sv * C57BL/6 * CBA)
brain inflammation J:216422
Fxntm1Mkn/Fxntm1Pand
(involves: 129/Sv * C57BL/6)
brain inflammation J:216422
Fyntm1Rmp/Fyntm1Rmp
(B6.129S2-Fyntm1Rmp)
increased susceptibility to type I hypersensitivity reaction J:114287
Gab2tm1Hhg/Gab2tm1Hhg
(involves: 129S4/SvJae)
decreased susceptibility to type I hypersensitivity reaction J:70424
Gab2tm3.1Thir/Gab2tm3.1Thir
(involves: 129T/SvJcl * C57BL/6Jcl)
decreased susceptibility to type I hypersensitivity reaction J:178045
Gab2tm4.1Thir/Gab2tm4.1Thir
(involves: 129T/SvJcl * C57BL/6Jcl)
decreased susceptibility to type I hypersensitivity reaction J:178045
Gad2tm1Miya/Gad2tm1Miya
(NOD.129P2-Gad2tm1Miya)
pancreas inflammation J:88785
Gadd45atm1Ajf/Gadd45atm1Ajf
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129X1/SvJ * C57BL/6))
glomerulonephritis J:76041
increased inflammatory response J:76041
Gadd45btm1Flv/Gadd45btm1Flv
(B6.129S6-Gadd45btm1Flv)
glomerulonephritis J:118837
Gadd45btm1Flv/Gadd45btm1Flv
Gadd45gtm1Flv/Gadd45gtm1Flv

(involves: 129S1/Sv * 129S6/SvEvTac * C57BL/6)
glomerulonephritis J:118837
Gadd45gtm1Flv/Gadd45gtm1Flv
(involves: 129S1/Sv)
abnormal type IV hypersensitivity reaction J:69475
Galctwi/Galctwi
(involves: CE/J)
CNS inflammation J:78223
GaltGt(E285B04)Wrst/GaltGt(E285B04)Wrst
(involves: 129P2/OlaHsd * C57BL/6J)
brain inflammation J:234753
liver inflammation J:234753
Gasa1BALB/cCrSlc/Gasa1BALB/cCrSlc
(involves: BALB/cCrSlc * C57BL/6)
stomach inflammation J:54699
Gasa1BALB/cCrSlc/Gasa1C57BL/6
(involves: BALB/cCrSlc * C57BL/6)
stomach inflammation J:54699
Gasa2BALB/cCrSlc/Gasa2BALB/cCrSlc
(involves: BALB/cCrSlc * C57BL/6)
stomach inflammation J:54699
Gasa2BALB/cCrSlc/Gasa2BALB/cCrSlc
Gasa4BALB/cCrSlc/Gasa4C57BL/6

(involves: BALB/cCrSlc * C57BL/6)
stomach inflammation J:75277
Gasa2BALB/cCrSlc/Gasa2C57BL/6
(involves: BALB/cCrSlc * C57BL/6)
stomach inflammation J:54699
Gasa3BALB/cCrSlc/Gasa3C57BL/6
(involves: BALB/cCrSlc * C57BL/6)
stomach inflammation J:75277
Gasa4BALB/cCrSlc/Gasa4C57BL/6
(involves: BALB/cCrSlc * C57BL/6)
stomach inflammation J:75277
Gasttm1Lcs/Gasttm1Lcs
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
stomach inflammation J:97527
Gata5tm1.2Nemr/Gata5tm1.2Nemr
(Not Specified)
kidney inflammation J:227997
Gata5tm1Eno/Gata5tm1Eno
(involves: 129S6/SvEvTac * C57BL/6)
urethritis J:63036
vaginal inflammation J:63036
Gatmem1Btlr/Gatmem1Btlr
(C57BL/6J-Gatmem1Btlr)
increased susceptibility to induced colitis J:252049
Gatmem1Btlr/Gatmm1Btlr
(C57BL/6J-Gatmem1Btlr/Gatmm1Btlr)
increased susceptibility to induced colitis J:252049
Gatmm1Btlr/Gatm+
(C57BL/6J-Gatmm1Btlr)
increased susceptibility to induced colitis J:252049
Gatmm1Btlr/Gatmm1Btlr
(C57BL/6J-Gatmm1Btlr)
increased susceptibility to induced colitis J:252049
Gbatm1Rlp/Gbatm1Rlp
(involves: 129S4/SvJae * C57BL/6)
abnormal inflammatory response J:76409
liver inflammation J:76409
lung inflammation J:76409
lymph node inflammation J:76409
skin inflammation J:76409
Gcatm1Roes/Gcatm1Roes
(involves: 129P2/OlaHsd * 129S2/SvPas)
decreased susceptibility to endotoxin shock J:81436
Gcnt1tm1Jxm/Gcnt1tm1Jxm
(involves: 129/Sv * C57BL/6)
abnormal acute inflammation J:86387
abnormal inflammatory response J:86387
Gcnt3tm1.1Jxm/Gcnt3tm1.1Jxm
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
increased susceptibility to induced colitis J:149909
Gdnftm1Lmgd/Gdnf+
(B6.129-Gdnftm1Lmgd)
tubulointerstitial nephritis J:103081
Gfaptm1Pkny/Gfaptm1Pkny
Ppt1tm1Hof/Ppt1tm1Hof
Vimtm1Cba/Vimtm1Cba

(involves: 129P2/OlaHsd * 129S2/SvPas * 129S6/SvEvTac * C57BL/6)
brain inflammation J:177265
Gfaptm1Pkny/Gfaptm1Pkny
Vimtm1Cba/Vimtm1Cba

(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
decreased inflammatory response J:123278
Gfertm1.1Crg/Gfertm1.1Crg
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+

(involves: 129 * C57BL/6 * DBA)
liver inflammation J:227242
Gfi1tm1Tmo/Gfi1tm1Tmo
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
increased susceptibility to endotoxin shock J:75143
Gfustm1Jbl/Gfustm1Jbl
(involves: 129S2/SvPas * C57BL/6J)
large intestinal inflammation J:82239
Ggt5tm1Mwl/Ggt5tm1Mwl
(involves: 129S7/SvEvBrd * C57BL/6J)
decreased acute inflammation J:77691
Gimap5m1Btlr/Gimap5m1Btlr
(involves: C57BL/6J)
colitis J:160090
intestinal inflammation J:160090
Git2tm1Hsb/Git2tm1Hsb
(involves: C57BL/6 * CBA)
lung inflammation J:112663
Gja1M1Jrt/Gja1+
(involves: C3H/HeJ * C57BL/6J)
heart inflammation J:101733
Gjb1tm1Kwi/Y
Gjc2tm1(EGFP)Kwi/Gjc2tm1(EGFP)Kwi

(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
optic nerve inflammation J:219594
spinal cord inflammation J:219594
Gjc2tm1(EGFP)Kwi/Gjc2tm1(EGFP)Kwi
Gjb1tm1Kwi/Gjb1tm1Kwi

(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
optic nerve inflammation J:219594
spinal cord inflammation J:219594
Gkn2tm1.1(KOMP)Vlcg/Gkn2tm1.1(KOMP